{"meta":{"query_hash":"d4c37e2a5671","filters":{"venue":"Cancer Investigation"},"cohort_total":50,"direct_labels_cover":0,"predictions_cover":50,"exported":50,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/d4c37e2a5671","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Investigation"},"results":[{"id":"W1681690519","doi":"10.3109/07357900009032835","title":"Should Tamoxifen Be Used to Treat Premenopausal Women with Breast Cancer?","year":2000,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Oncology; Gynecology; Cancer; Antiestrogen; Internal medicine","score_opus":0.02092861951392712,"score_gpt":0.2693552913173837,"score_spread":0.24842667180345662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1681690519","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02884702,0.20063795,0.0007225861,0.73669076,0.01024507,0.00007157724,0.00039765344,0.00009753618,0.022289766],"genre_scores_gemma":[0.2088937,0.18558273,0.0042379214,0.560575,0.022417737,0.00014899034,0.0005356821,0.000040013456,0.017568193],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99920243,0.00026860906,0.00014265624,0.00005948595,0.0002537536,0.000073072806],"domain_scores_gemma":[0.99763405,0.00073285616,0.0007600727,0.00006829039,0.00059034367,0.00021435076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002074482,0.00023716764,0.0006923506,0.0003762833,0.00065961806,0.00073572143,0.00047107175,0.004098483,0.0033527587],"category_scores_gemma":[0.00965406,0.00016060569,0.0004739268,0.00056354696,0.00074220187,0.00090320234,0.00025073145,0.0020933482,0.0016200198],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004087681,0.0004282292,0.022634583,0.0018467907,0.00037120673,0.00263974,0.00047045262,0.00015896547,0.0070134914,0.0030057384,0.37447372,0.5828694],"study_design_scores_gemma":[0.0012662401,0.0017289922,0.041912742,0.0019767766,0.0009237341,0.0052759885,0.00086068205,0.0001831087,0.0034159624,0.0041553434,0.93821347,0.00008691647],"about_ca_topic_score_codex":0.002171626,"about_ca_topic_score_gemma":0.009815177,"teacher_disagreement_score":0.004098483,"about_ca_system_score_codex":0.000660585,"about_ca_system_score_gemma":0.0014821988,"threshold_uncertainty_score":0.011216104},"labels":[],"label_agreement":null},{"id":"W1787613411","doi":"10.3109/07357907.2015.1060996","title":"Claudin 1 Promotes Migration and Increases Sensitivity to Tamoxifen and Anticancer Drugs in Luminal-like Human Breast Cancer Cells MCF7","year":2015,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Downregulation and upregulation; Breast cancer; Claudin; Tamoxifen; Cancer research; Etoposide; Cancer; Medicine; Cisplatin; Oncology; Internal medicine; Tight junction; Chemistry; Biology; Chemotherapy; Cell biology","score_opus":0.04357083030038854,"score_gpt":0.2891912493118925,"score_spread":0.24562041901150394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1787613411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744725,0.0013726373,0.0002928818,0.00011123146,0.000008178983,0.0000040737164,0.00010750184,0.000019062623,0.00063726027],"genre_scores_gemma":[0.99728,0.0011223658,0.0002926978,0.00003750046,0.0000040823743,0.000008629062,0.00026705346,0.0000034372092,0.0009842471],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999436,0.000009306174,0.000003274635,0.00000789783,0.000016145395,0.000019862604],"domain_scores_gemma":[0.9999546,0.000006609291,0.000010814637,0.0000038474486,0.000010047429,0.000014081532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008748956,0.00010674853,0.00015609394,0.00026039936,0.00019711923,0.00021728738,0.00006579848,0.00014898287,0.0008265616],"category_scores_gemma":[0.000099658435,0.00007496251,0.0001480687,0.00016250412,0.00009015221,0.00012407536,0.000109987166,0.00028921245,0.00019452191],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015288455,0.000040110448,0.0013458472,0.00003313086,0.0000067063065,0.00008297109,0.000061319224,0.000035665413,0.9961034,0.000082748804,0.00012453666,0.001930676],"study_design_scores_gemma":[0.000030123494,0.0010059137,0.101910956,0.000021633978,0.000044507247,0.0008663265,0.00051687617,0.0013509784,0.8875085,0.00014391662,0.0065880786,0.000012139474],"about_ca_topic_score_codex":0.0013632074,"about_ca_topic_score_gemma":0.0015554383,"teacher_disagreement_score":0.0013632074,"about_ca_system_score_codex":0.00019819723,"about_ca_system_score_gemma":0.00015536604,"threshold_uncertainty_score":0.002765119},"labels":[],"label_agreement":null},{"id":"W1972192442","doi":"10.1081/cnv-200050453","title":"Benefit of Temozolomide Compared to Procarbazine in Treatment of Glioblastoma Multiforme at First Relapse: Effect on Neurological Functioning, Performance Status, and Health Related Quality of Life","year":2005,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Procarbazine; Temozolomide; Glioblastoma; Medicine; Quality of life (healthcare); Oncology; Karnofsky Performance Status; Health related quality of life; Internal medicine; Overall survival; Chemotherapy; Vincristine; Cancer research; Disease","score_opus":0.05254147227967874,"score_gpt":0.3164567422638571,"score_spread":0.26391526998417836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972192442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947719,0.0044160984,0.00008505341,0.00025576726,0.00004738832,0.00002952865,0.000054897548,0.000008670023,0.00033064137],"genre_scores_gemma":[0.9983407,0.0010813893,0.00014935614,0.00009265442,0.00005055095,0.00002194519,0.000060973813,0.000002259283,0.00020017155],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997023,0.0001795302,0.000026109396,0.000024247163,0.000031254873,0.000036640067],"domain_scores_gemma":[0.9994931,0.00019927777,0.00014251564,0.000024900948,0.000020592723,0.00011955875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081915816,0.0003130217,0.0015807014,0.00027597786,0.00010271558,0.0002606008,0.00017264644,0.0004093032,0.0008879695],"category_scores_gemma":[0.0014775342,0.0001130112,0.0005810465,0.00025907572,0.00027658502,0.00031721924,0.00015998652,0.00085841335,0.000085718995],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7769389,0.0044853725,0.010185006,0.00086877815,0.0017338486,0.00026870138,0.00011760719,0.0020518422,0.01988397,0.00026805536,0.00081325404,0.18238473],"study_design_scores_gemma":[0.12900431,0.64685905,0.19301426,0.00019947282,0.0048478693,0.0011005241,0.00015888292,0.005251456,0.015638197,0.0007882801,0.0030450064,0.00009261339],"about_ca_topic_score_codex":0.0006852092,"about_ca_topic_score_gemma":0.0026589013,"teacher_disagreement_score":0.0015807014,"about_ca_system_score_codex":0.00038275777,"about_ca_system_score_gemma":0.0003955667,"threshold_uncertainty_score":0.004332185},"labels":[],"label_agreement":null},{"id":"W1974941133","doi":"10.3109/07357907.2013.820319","title":"The Use of Salivary Protein Secretions as an<i>In Vivo</i>Model to Study Mantel Cell Lymphoma Progression and Treatment","year":2013,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institute for Theoretical Astrophysics","keywords":"In vivo; Saliva; Salivary Proteins; Chemotherapy; Lymphoma; Medicine; Salivary gland; Oncology; Internal medicine; Cancer research; Pathology; Immunology; Biology","score_opus":0.06818538827177109,"score_gpt":0.31944437943282394,"score_spread":0.2512589911610529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974941133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915815,0.0028388684,0.0037760306,0.00021530486,0.000055679986,0.00014757339,0.00023798688,0.00008041726,0.0010665145],"genre_scores_gemma":[0.9929416,0.0014527672,0.003849874,0.00014268837,0.00003053618,0.00013415777,0.00035275015,0.000013732162,0.0010818801],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980336,0.00007402471,0.000011821464,0.000039638977,0.0000400633,0.000031200612],"domain_scores_gemma":[0.9998754,0.000024024368,0.00004208385,0.000018885845,0.000016997123,0.000022535984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035845663,0.00042032267,0.00031462748,0.00031532958,0.00024394445,0.000522889,0.00021779162,0.00039405614,0.0010284107],"category_scores_gemma":[0.00023589996,0.0001208954,0.00030006,0.00021086233,0.00034998436,0.00040156025,0.00030465395,0.00070318364,0.00026061918],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010374632,0.0004181268,0.0033815792,0.00009706272,0.000019377458,0.00016108237,0.00006056422,0.00008931592,0.98914856,0.00006975342,0.000088153036,0.0054290043],"study_design_scores_gemma":[0.000083314335,0.011734271,0.0296872,0.000023779705,0.00011159944,0.0016549577,0.00033419477,0.0014916959,0.95127463,0.00013096513,0.0034574976,0.000015898786],"about_ca_topic_score_codex":0.0003755315,"about_ca_topic_score_gemma":0.0005000326,"teacher_disagreement_score":0.0010284107,"about_ca_system_score_codex":0.00028349334,"about_ca_system_score_gemma":0.00027839543,"threshold_uncertainty_score":0.00344038},"labels":[],"label_agreement":null},{"id":"W1986130879","doi":"10.3109/07357907.2014.919306","title":"Changes in PKM2 Associate with Prostate Cancer Progression","year":2014,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"PKM2; Prostate cancer; Cancer research; Anaerobic glycolysis; Pyruvate kinase; Cancer; Medicine; Warburg effect; Prostate; Cancer stem cell; Glycolysis; Cancer cell; Oncology; Internal medicine; Metabolism","score_opus":0.012877886601504808,"score_gpt":0.27287641856354394,"score_spread":0.25999853196203915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986130879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952683,0.0019525884,0.0010754145,0.00007723176,0.000015128073,0.000017158609,0.00039583084,0.00006131394,0.0011370222],"genre_scores_gemma":[0.99556434,0.000619501,0.0007882943,0.000028084496,0.000012837361,0.000024793559,0.00063078734,0.000007999288,0.0023234503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990535,0.000009987019,0.0000048742286,0.000025331012,0.000025874653,0.000028595245],"domain_scores_gemma":[0.9998913,0.000008262407,0.00003704201,0.0000071968334,0.000015106063,0.00004100896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088624154,0.00020075479,0.0001403912,0.00038760412,0.00019637542,0.0003085745,0.00009895343,0.00017452719,0.0016382352],"category_scores_gemma":[0.000102696875,0.00015971855,0.00017772836,0.00033655472,0.00016546508,0.00015517061,0.00019396534,0.00042173365,0.00037543912],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049876,0.000044978504,0.008230459,0.00003533195,0.000016471582,0.00015115988,0.00003591694,0.000054216205,0.9879681,0.000059224025,0.00013177961,0.0027735939],"study_design_scores_gemma":[0.000027190657,0.00047768196,0.3640472,0.000006813364,0.00003853325,0.0016129218,0.00011606908,0.00079737545,0.6280758,0.00014975728,0.00463545,0.000015155863],"about_ca_topic_score_codex":0.0004939213,"about_ca_topic_score_gemma":0.00056163344,"teacher_disagreement_score":0.0016382352,"about_ca_system_score_codex":0.00021875436,"about_ca_system_score_gemma":0.00017106938,"threshold_uncertainty_score":0.0054804087},"labels":[],"label_agreement":null},{"id":"W1986576258","doi":"10.3109/07357900903095672","title":"Recombinant Human Interleukin-24 Suppresses Gastric Carcinoma Cell Growth<i>In Vitro</i>and<i>In Vivo</i>","year":2009,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"In vivo; Cancer research; Angiogenesis; Biology; Cancer; In vitro; Molecular biology; Cancer cell; Biochemistry","score_opus":0.020374268392780448,"score_gpt":0.2768438347979642,"score_spread":0.25646956640518376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986576258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99191475,0.0035402866,0.0014733486,0.00014359699,0.000062599494,0.000033381424,0.0004735794,0.00021678758,0.0021418235],"genre_scores_gemma":[0.99328977,0.0015559475,0.0014477405,0.00008939184,0.000019271485,0.000057682584,0.0012408989,0.000026011829,0.0022733535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999014,0.000022590022,0.0000107344085,0.000011571132,0.000026495047,0.000027249207],"domain_scores_gemma":[0.99992,0.000016275117,0.00001909682,0.000012681797,0.000010729706,0.000021243079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011046224,0.00036787105,0.00025475054,0.00017600853,0.00007920917,0.00019243968,0.0001346042,0.00013907293,0.0009214643],"category_scores_gemma":[0.000092481176,0.00006745805,0.00025168157,0.00012272828,0.00017921909,0.00006898099,0.00009262379,0.00044895775,0.0004049103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022981729,0.00009046078,0.00020679562,0.000046504018,0.0000061107776,0.000056684916,0.0000126661125,0.00008194849,0.9977847,0.000046874968,0.00015166981,0.0012858608],"study_design_scores_gemma":[0.00004717958,0.0008967921,0.0022120164,0.000004506591,0.000018575556,0.0002054536,0.0000183582,0.0010234427,0.99278533,0.000020851108,0.0027644592,0.0000030701729],"about_ca_topic_score_codex":0.0008556609,"about_ca_topic_score_gemma":0.00077598717,"teacher_disagreement_score":0.0009214643,"about_ca_system_score_codex":0.00024850218,"about_ca_system_score_gemma":0.0002269187,"threshold_uncertainty_score":0.0030825734},"labels":[],"label_agreement":null},{"id":"W1998582467","doi":"10.1080/07357900601063790","title":"Clinical Activity of Celecoxib in Metastatic Malignant Melanoma","year":2006,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Celecoxib; Melanoma; Metastatic melanoma; Internal medicine; Metastasis; Disease; Oncology; Stage (stratigraphy); Progressive disease; Cancer; Gastroenterology; Surgery; Cancer research","score_opus":0.04155444907087426,"score_gpt":0.33558109085562865,"score_spread":0.2940266417847544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998582467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851909,0.01107572,0.00014300372,0.00018044071,0.000031949887,0.000036402067,0.00006555954,0.000016488544,0.00325949],"genre_scores_gemma":[0.9969963,0.0020921805,0.00008782154,0.0000618256,0.000060988288,0.00001138203,0.00010266174,0.0000018777959,0.00058497855],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99989223,0.00003029226,0.000010076549,0.000008758783,0.00003742882,0.000021192567],"domain_scores_gemma":[0.99974173,0.00006430915,0.000054230066,0.000009691301,0.00003952416,0.00009051926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002926839,0.00016990303,0.0003681019,0.00024900783,0.00021374301,0.00020536003,0.00007438253,0.00014517987,0.0008865982],"category_scores_gemma":[0.0012148272,0.00006299051,0.000146096,0.00017817495,0.00013684844,0.000104336636,0.00008901818,0.00030874988,0.00019405285],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027727121,0.0017583173,0.27317315,0.0008363971,0.0003383347,0.018710308,0.00045429193,0.0015073043,0.2794244,0.00042631503,0.00368611,0.39195806],"study_design_scores_gemma":[0.0026023071,0.08505246,0.7665666,0.00016773428,0.00055745256,0.044070818,0.0003169281,0.0030787413,0.06792041,0.0004113909,0.029215641,0.000039548067],"about_ca_topic_score_codex":0.0006371093,"about_ca_topic_score_gemma":0.0018633194,"teacher_disagreement_score":0.0008865982,"about_ca_system_score_codex":0.0003043404,"about_ca_system_score_gemma":0.0001791212,"threshold_uncertainty_score":0.0029659271},"labels":[],"label_agreement":null},{"id":"W2002650137","doi":"10.1080/07357900600629575","title":"Rat PSP94 Inhibits the Growth and Viability of the Rat Adenocarcinoma Cell Line PAIII In Vitro","year":2006,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Lawson Health Research Institute; Western University","funders":"","keywords":"In vitro; Apoptosis; Cell culture; Biology; In vivo; Programmed cell death; Annexin; Cell growth; TUNEL assay; Adenocarcinoma; Cell biology; Viability assay; Cancer research; Molecular biology; Cancer; Biochemistry; Genetics","score_opus":0.010358066752972562,"score_gpt":0.2146727353138076,"score_spread":0.20431466856083502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002650137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98057026,0.0052107866,0.007263243,0.00020218127,0.00007168697,0.00005754488,0.0010510049,0.0003224752,0.0052508563],"genre_scores_gemma":[0.9776848,0.0042065457,0.0055772387,0.00008373145,0.00002406703,0.00006657585,0.0027234717,0.000064947715,0.00956869],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996892,0.000053449927,0.00002715948,0.000026973938,0.0001449696,0.000058280377],"domain_scores_gemma":[0.9997422,0.00007864994,0.00004537507,0.000043539836,0.0000406098,0.00004948978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018638794,0.00050008006,0.00043684503,0.00046874117,0.00018033588,0.00030152366,0.00024351363,0.00024019062,0.0018131947],"category_scores_gemma":[0.00031278306,0.00015524164,0.00033798412,0.00038291945,0.00017453052,0.00013177683,0.0002584104,0.0008813689,0.00078773504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007059929,0.00004560907,0.00014725288,0.000030106998,0.0000063059874,0.000053252075,0.00001937552,0.000111856694,0.9979626,0.000059674087,0.00007455889,0.0014189486],"study_design_scores_gemma":[0.000011855168,0.0007088566,0.0016674901,0.000004281741,0.000009465096,0.00023359152,0.000023185185,0.0006291169,0.9948502,0.000025481482,0.0018335396,0.000002861971],"about_ca_topic_score_codex":0.002170966,"about_ca_topic_score_gemma":0.0019335046,"teacher_disagreement_score":0.002170966,"about_ca_system_score_codex":0.00029455498,"about_ca_system_score_gemma":0.0003530456,"threshold_uncertainty_score":0.006065786},"labels":[],"label_agreement":null},{"id":"W2005398645","doi":"10.1080/07357900600814839","title":"A Sequential Scanning of the Immune Efficiency in Astrocytoma (Grade I to Grade III), Meningioma and Secondary Glioma Patients with and without Therapeutic Scheduling","year":2006,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Astrocytoma; Meningioma; Glioma; Medicine; Immune system; Oncology; Internal medicine; Surgery; Cancer research; Immunology","score_opus":0.01712194722769551,"score_gpt":0.26227622961268676,"score_spread":0.24515428238499126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005398645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994529,0.00014866261,0.00003885822,0.00000656787,0.0000018792981,0.0000057194275,0.00003314821,0.0000023525056,0.00030989293],"genre_scores_gemma":[0.999757,0.000041189225,0.000029952655,0.0000048281195,0.0000020469276,0.00000325625,0.00005107977,4.129715e-7,0.000110293484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999324,0.000010904768,0.000007491928,0.000018587565,0.000013162318,0.000017423376],"domain_scores_gemma":[0.9997918,0.00001944025,0.000088779336,0.000011903877,0.000024073937,0.00006397024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008040228,0.00014288211,0.00018790257,0.00028010705,0.00016254954,0.000150371,0.00006315267,0.00013893137,0.00079128565],"category_scores_gemma":[0.00035951004,0.000058729376,0.00016434694,0.00017922353,0.00012386212,0.000116481126,0.000104148065,0.00018722296,0.0001171365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037445757,0.00021102779,0.9652284,0.00005075851,0.000072458184,0.0010098304,0.00025941493,0.00014112986,0.015771164,0.00004277859,0.00015191572,0.0133164795],"study_design_scores_gemma":[0.000019584852,0.002649622,0.993112,0.000003720348,0.00004930073,0.0019811396,0.00014304684,0.00012887291,0.0015119071,0.000029328066,0.00036624947,0.000005121575],"about_ca_topic_score_codex":0.0007395761,"about_ca_topic_score_gemma":0.0010319179,"teacher_disagreement_score":0.00079128565,"about_ca_system_score_codex":0.00015931396,"about_ca_system_score_gemma":0.000114065806,"threshold_uncertainty_score":0.0026471019},"labels":[],"label_agreement":null},{"id":"W2007519119","doi":"10.1080/07357900701208683","title":"Telomere Biology of Pediatric Cancer","year":2007,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Telomerase; Telomere; Telomerase reverse transcriptase; Cancer; Biology; Cancer research; Pediatric cancer; Mechanism (biology); Genetics; DNA; Gene","score_opus":0.20062530421029603,"score_gpt":0.44177627668692215,"score_spread":0.24115097247662612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007519119","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000993925,0.9990017,0.000059755308,0.0002142546,0.00011409499,0.000001924884,0.000004625512,0.000003221613,0.00050108565],"genre_scores_gemma":[0.0005565775,0.99874985,0.00009282739,0.00011735298,0.00014095847,0.0000033169138,0.000009895697,5.699176e-7,0.00032870017],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984074,0.00003088318,0.000024580877,0.000029176766,0.000058892336,0.000015802132],"domain_scores_gemma":[0.99972135,0.000109150176,0.000049960203,0.00000882449,0.00007727634,0.000033507036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006089743,0.0008350947,0.0013324934,0.0019202753,0.00039081002,0.00082635094,0.000653467,0.0011197259,0.002228222],"category_scores_gemma":[0.0007193646,0.0002505164,0.00037383143,0.0018423522,0.00050360867,0.0013502564,0.00063418713,0.0016008851,0.001601584],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006623167,0.00004961847,0.00048721125,0.007866375,0.000048841102,0.00044124617,0.00008444734,0.00031291664,0.0012105162,0.003497162,0.026363963,0.9595714],"study_design_scores_gemma":[0.000018417824,0.00009189199,0.0015149114,0.0029230702,0.00007225821,0.003976966,0.00008206933,0.0000809377,0.0004986701,0.0023241094,0.9884001,0.00001652094],"about_ca_topic_score_codex":0.0013489968,"about_ca_topic_score_gemma":0.0023939335,"teacher_disagreement_score":0.002228222,"about_ca_system_score_codex":0.00076445995,"about_ca_system_score_gemma":0.001089225,"threshold_uncertainty_score":0.007454157},"labels":[],"label_agreement":null},{"id":"W2012331446","doi":"10.3109/07357900009012213","title":"Greater Expectations in a Cancer Trial: Absolute More Than Relative Survival Increases, Community More Than Academic Clinicians","year":2000,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Absolute (philosophy); Cancer; Medicine; Relative survival; Oncology; Internal medicine; Cancer registry","score_opus":0.5209175464903644,"score_gpt":0.4872048355757998,"score_spread":0.03371271091456457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012331446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91245794,0.0040075826,0.0037183035,0.06620146,0.0003586491,0.00029694432,0.000056398323,0.000047641573,0.012855225],"genre_scores_gemma":[0.99066377,0.0005401466,0.001086165,0.0072111874,0.00021256325,0.00008635811,0.0000141206365,0.000008530037,0.00017719397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.8751566,0.10742331,0.00363601,0.0016096499,0.010566233,0.0016082051],"domain_scores_gemma":[0.73483545,0.17821339,0.049268074,0.003895423,0.016274352,0.017513344],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.095263585,0.00022741708,0.00054306554,0.0006785392,0.002173522,0.004357315,0.00073324755,0.0024289812,0.0023154016],"category_scores_gemma":[0.27084848,0.0003706365,0.00044003752,0.00068754604,0.004790425,0.0028296786,0.002718016,0.0032473183,0.0002336225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010807388,0.0019939346,0.4366233,0.005925353,0.0009518074,0.0017345012,0.25825015,0.0023399438,0.011818501,0.014346585,0.025432894,0.22977562],"study_design_scores_gemma":[0.002737151,0.01111204,0.5606584,0.0044576805,0.0009511401,0.0035024856,0.28555542,0.0045222426,0.0048663127,0.03933337,0.081453346,0.00085039175],"about_ca_topic_score_codex":0.001964843,"about_ca_topic_score_gemma":0.003216709,"teacher_disagreement_score":0.9047364,"about_ca_system_score_codex":0.004285747,"about_ca_system_score_gemma":0.006056242,"threshold_uncertainty_score":0.503808},"labels":[],"label_agreement":null},{"id":"W2017601541","doi":"10.1080/07357900701518388","title":"Adjuvant Therapy with Raltitrexed in Patients with Colorectal Cancer Intolerant of 5-Fluorouracil: British Columbia Cancer Agency Experience","year":2007,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Raltitrexed; Medicine; Colorectal cancer; Cancer; Fluorouracil; Adjuvant; Oncology; Internal medicine; Adjuvant therapy; Oxaliplatin","score_opus":0.017782034611391728,"score_gpt":0.2747893821367695,"score_spread":0.2570073475253778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017601541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457574,0.002267858,0.00005674697,0.00033272058,0.000007873831,0.00003187178,0.00007285907,0.0000027808642,0.0026516235],"genre_scores_gemma":[0.9965655,0.0021627008,0.00011974545,0.00026419968,0.000023472705,0.000013085738,0.00017676261,0.000002514789,0.00067188503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996666,0.00009240572,0.000028400911,0.00003193203,0.00009484964,0.00008589028],"domain_scores_gemma":[0.9991855,0.0001748263,0.00022192727,0.000035651727,0.00013394827,0.0002480961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004468006,0.00011973254,0.00017973059,0.0002580758,0.00066997844,0.00043165786,0.00020997616,0.0002452191,0.0011641363],"category_scores_gemma":[0.0018106549,0.00010823353,0.00012031394,0.000765227,0.00032839229,0.00016752332,0.00030043127,0.00040145786,0.00013901008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014328787,0.0004079134,0.9408298,0.00012530733,0.00004877386,0.0038917058,0.00079590775,0.00017631406,0.0022716373,0.0000920365,0.0017232087,0.048204586],"study_design_scores_gemma":[0.0002862166,0.0024820871,0.9721886,0.00009792846,0.00010783438,0.009989241,0.000799089,0.00041187214,0.0008021633,0.00005938019,0.012754898,0.000020673479],"about_ca_topic_score_codex":0.13082765,"about_ca_topic_score_gemma":0.2874082,"teacher_disagreement_score":0.86917233,"about_ca_system_score_codex":0.0015559292,"about_ca_system_score_gemma":0.0023426786,"threshold_uncertainty_score":0.2601323},"labels":[],"label_agreement":null},{"id":"W2021704241","doi":"10.3109/07357907.2010.483508","title":"Disease Progression Increases the Risk of Skeletal-Related Events in Patients With Bone Metastases From Castration-Resistant Prostate Cancer, Lung Cancer, or Other Solid Tumors","year":2010,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Bone health and treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Zoledronic acid; Prostate cancer; Oncology; Cancer; Internal medicine; Lung cancer; Disease; Prostate","score_opus":0.012631920879963617,"score_gpt":0.3072983779499667,"score_spread":0.29466645707000305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021704241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957967,0.0030154549,0.00021140283,0.00013058838,0.000008033467,0.000035289155,0.00018817121,0.0000067942883,0.00060757855],"genre_scores_gemma":[0.9983145,0.0007756857,0.0002325606,0.00006789835,0.000022885215,0.000017154052,0.000362305,0.0000013773912,0.00020559311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932957,0.00041446934,0.00004863798,0.00006112263,0.00009861517,0.00004761915],"domain_scores_gemma":[0.9983132,0.0008012106,0.00060266413,0.00007838015,0.0000447091,0.00015977416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018094806,0.00023853828,0.00077673106,0.0003226865,0.00018488361,0.00038697483,0.00023671176,0.00044339217,0.0014255499],"category_scores_gemma":[0.0023935703,0.00021316866,0.0014158592,0.00049442786,0.00022109048,0.00023041597,0.00021945816,0.00079168583,0.00009583273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058439553,0.0010426329,0.87610555,0.00036700847,0.0032333944,0.000345116,0.00009059198,0.0014181974,0.0051427432,0.00023731284,0.0005535604,0.053024516],"study_design_scores_gemma":[0.0034010606,0.012694809,0.97829616,0.00003323213,0.0015476122,0.00065026304,0.000042910488,0.0014225626,0.00063481455,0.0003604674,0.0009024556,0.000013615929],"about_ca_topic_score_codex":0.0008465593,"about_ca_topic_score_gemma":0.0030627453,"teacher_disagreement_score":0.0018094806,"about_ca_system_score_codex":0.00018817025,"about_ca_system_score_gemma":0.0004992623,"threshold_uncertainty_score":0.009569526},"labels":[],"label_agreement":null},{"id":"W2028160062","doi":"10.1081/cnv-120027590","title":"The Role of Surrogate Markers in the Clinical Development of Antiretroviral Therapy: A Model for Early Evaluation of Targeted Cancer Drugs","year":2004,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; St. Paul's Hospital; University of British Columbia; McGill University; McGill University Health Centre","funders":"","keywords":"Surrogate endpoint; Medicine; Clinical trial; Drug resistance; Efficacy; Drug development; Drug; Targeted therapy; Oncology; Cancer; Immunology; Internal medicine; Pharmacology; Biology","score_opus":0.15887438748470356,"score_gpt":0.4261522573596967,"score_spread":0.26727786987499313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028160062","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009209115,0.9953992,0.0014983327,0.0015744244,0.00030395456,0.000014352286,0.0000087868575,0.000013314848,0.001095668],"genre_scores_gemma":[0.0016982624,0.99435025,0.0023124493,0.0007171368,0.00035479775,0.000042185984,0.00001412256,0.000004746426,0.00050610607],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715436,0.0016398875,0.0002808795,0.00019241998,0.0006631601,0.000069204034],"domain_scores_gemma":[0.9940289,0.0044850498,0.00038205154,0.00021339068,0.0007582895,0.00013239005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0081134075,0.0018179207,0.0036792024,0.003479031,0.00037411076,0.0026735489,0.0022244724,0.0037813655,0.0018395748],"category_scores_gemma":[0.006506075,0.00070191815,0.001101841,0.002830354,0.003244116,0.0045055626,0.0012315395,0.0067074494,0.001950242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015857599,0.0001470403,0.0003358389,0.01194152,0.0001842804,0.0003826475,0.00021704409,0.0025804124,0.0013675614,0.078935325,0.022737341,0.8810123],"study_design_scores_gemma":[0.00009499842,0.0003337531,0.00078429334,0.008109238,0.00015737559,0.0015910098,0.00017439038,0.0012744111,0.00072043587,0.04725623,0.9394326,0.0000712848],"about_ca_topic_score_codex":0.0014866706,"about_ca_topic_score_gemma":0.0013510328,"teacher_disagreement_score":0.0081134075,"about_ca_system_score_codex":0.0028659196,"about_ca_system_score_gemma":0.0025640444,"threshold_uncertainty_score":0.04290837},"labels":[],"label_agreement":null},{"id":"W2031379570","doi":"10.1081/cnv-67172","title":"State of the Art in Therapy for Non-Small Cell Lung Cancer","year":2005,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lung cancer; Disease; Chemotherapy; Radiation therapy; Intensive care medicine; Quality of life (healthcare); Oncology; Cancer; Adjuvant chemotherapy; Internal medicine; Surgery; Breast cancer; Nursing","score_opus":0.058486521006174144,"score_gpt":0.3933712949867484,"score_spread":0.33488477398057426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031379570","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039546623,0.9981086,0.00008794904,0.00031997822,0.00026193858,0.000004619632,0.000008615641,0.0000066842185,0.0011620184],"genre_scores_gemma":[0.0002173157,0.9986247,0.00017964169,0.00021242091,0.00019099959,0.000004894273,0.000015362088,0.0000014556655,0.0005531879],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995921,0.00008657259,0.000054635442,0.000057992467,0.00018303593,0.000025622969],"domain_scores_gemma":[0.9991943,0.0004676035,0.00009626253,0.000030213692,0.00016305057,0.00004860997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011909924,0.0010849067,0.0019290992,0.0024712966,0.00039788295,0.0012029399,0.0014302152,0.0015936935,0.0062820297],"category_scores_gemma":[0.001221663,0.0003228819,0.0006648502,0.0037368985,0.0007968552,0.002039839,0.0006818934,0.0027824224,0.0060086683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046384903,0.00005984128,0.000087630004,0.012217008,0.00005441709,0.0001511952,0.00004671853,0.00026545103,0.0008224521,0.002597963,0.038894817,0.94475627],"study_design_scores_gemma":[0.000013484011,0.0000505617,0.00036759517,0.0035885219,0.000048903832,0.00076773926,0.000032871074,0.000046669433,0.00017418209,0.0011842519,0.9937157,0.000009657796],"about_ca_topic_score_codex":0.00142204,"about_ca_topic_score_gemma":0.0025904484,"teacher_disagreement_score":0.0062820297,"about_ca_system_score_codex":0.0009027416,"about_ca_system_score_gemma":0.0013122695,"threshold_uncertainty_score":0.021015465},"labels":[],"label_agreement":null},{"id":"W2036049436","doi":"10.1081/cnv-100000076","title":"The Role of Genetic Factors in the Etiology of Pancreatic Adenocarcinoma: An Update","year":2001,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal; Montreal General Hospital; McGill University","funders":"","keywords":"Etiology; Adenocarcinoma; Medicine; Oncology; Cancer research; Internal medicine; Bioinformatics; Biology; Cancer","score_opus":0.10782959290599846,"score_gpt":0.4004338703383076,"score_spread":0.2926042774323091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036049436","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002337894,0.9978308,0.00014834915,0.00051259075,0.00031033947,0.0000040837335,0.0000151254235,0.00000886558,0.00093605614],"genre_scores_gemma":[0.0006118656,0.99806494,0.00020203769,0.00025128294,0.00043903795,0.000004085662,0.000021168085,8.575012e-7,0.00040475145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996555,0.00009596965,0.000063187115,0.000047090136,0.00011336948,0.000025001584],"domain_scores_gemma":[0.9986689,0.00083492324,0.00013374972,0.000032939413,0.00024462614,0.00008484576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010699808,0.0013477844,0.0024914595,0.0035890893,0.00033455307,0.0013059884,0.0016967771,0.001984791,0.0039293035],"category_scores_gemma":[0.0014528795,0.00037639562,0.000653495,0.0035002055,0.0006343503,0.002704728,0.0006240038,0.0014436151,0.0028821868],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013309358,0.00012103454,0.0012945908,0.008745821,0.00015834233,0.0023078094,0.00009850686,0.0003927575,0.0006309495,0.0012470677,0.041836355,0.9430336],"study_design_scores_gemma":[0.000060430284,0.0002532264,0.0057563013,0.0077480706,0.00047005268,0.013491479,0.00024053386,0.00024261748,0.0003406325,0.0022211194,0.96913123,0.000044401626],"about_ca_topic_score_codex":0.0023865008,"about_ca_topic_score_gemma":0.004407348,"teacher_disagreement_score":0.0039293035,"about_ca_system_score_codex":0.00078757707,"about_ca_system_score_gemma":0.0009389034,"threshold_uncertainty_score":0.013144851},"labels":[],"label_agreement":null},{"id":"W2037050175","doi":"10.1080/07357900802574660","title":"Pharmacology and Pharmacogenetics of Chemotherapeutic Agents","year":2009,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Pharmacogenetics; Personalized medicine; Chemotherapeutic drugs; Medicine; Drug; Pharmacology; Precision medicine; Clinical pharmacology; Drug response; Intensive care medicine; Chemotherapy; Bioinformatics; Internal medicine; Biology; Pathology; Genotype","score_opus":0.3330410630973113,"score_gpt":0.5339622308067224,"score_spread":0.20092116770941115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037050175","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032101257,0.9814516,0.004312682,0.0014344964,0.0001909699,0.000034892753,0.0001328309,0.000048198075,0.009184205],"genre_scores_gemma":[0.018141916,0.9756875,0.0025009369,0.0004783454,0.00023019854,0.000043571228,0.00012996882,0.0000067002484,0.0027808677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996345,0.000112495276,0.000037923754,0.000059637856,0.00013427222,0.000021167536],"domain_scores_gemma":[0.999665,0.00015297576,0.00007051593,0.000018658564,0.00007765428,0.000015124913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004834602,0.00046042458,0.001075658,0.0011297787,0.00018361711,0.0007800641,0.0005115699,0.0006094011,0.0016890977],"category_scores_gemma":[0.00083196093,0.00022807789,0.0004466671,0.0013678409,0.0004350365,0.00049305736,0.0004032485,0.001018032,0.0012447401],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013666524,0.00014184412,0.003175092,0.006346815,0.00017646003,0.0011858332,0.00009320667,0.0018813439,0.018881936,0.010708381,0.011116036,0.9461563],"study_design_scores_gemma":[0.000048817794,0.00037321632,0.0120096,0.0016907308,0.00028982083,0.012100538,0.00010445028,0.0011677853,0.02104633,0.013048319,0.9380579,0.00006249157],"about_ca_topic_score_codex":0.0009360135,"about_ca_topic_score_gemma":0.0013076258,"teacher_disagreement_score":0.0016890977,"about_ca_system_score_codex":0.000604112,"about_ca_system_score_gemma":0.00081188645,"threshold_uncertainty_score":0.0056506395},"labels":[],"label_agreement":null},{"id":"W2052268895","doi":"10.3109/07357907.2011.626474","title":"Tumor Endothelial Marker 8 Overexpression in Breast Cancer Cells Enhances Tumor Growth and Metastasis","year":2011,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cancer research; Breast cancer; Metastasis; Biology; Phenotype; Cancer; Pathology; In vivo; Medicine; Internal medicine; Gene","score_opus":0.018284032326623633,"score_gpt":0.24710892409511098,"score_spread":0.22882489176848736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052268895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694014,0.00096277514,0.00046569333,0.00006493463,0.000014424903,0.0000065255117,0.00009704405,0.000046772846,0.0014017597],"genre_scores_gemma":[0.99599695,0.00083590334,0.0007352923,0.000028010658,0.0000056842346,0.000015180787,0.00026241518,0.000009023857,0.0021115746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990547,0.000021805507,0.000007446424,0.000008582723,0.000027802163,0.000028959954],"domain_scores_gemma":[0.9999368,0.000015500596,0.000012773568,0.0000084468475,0.000007786804,0.00001874201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112677844,0.00016986285,0.00018192045,0.00016075047,0.00008359977,0.00018614021,0.00008526491,0.00015645291,0.0011502081],"category_scores_gemma":[0.000078664176,0.00010684486,0.00011623768,0.00016320057,0.00009499186,0.00013749301,0.000138804,0.00046349675,0.00042794438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098222605,0.000051448988,0.00019952745,0.000019778512,0.0000030761098,0.000041681553,0.000012713658,0.000051068477,0.9977635,0.00005446694,0.00007143434,0.001632994],"study_design_scores_gemma":[0.00002319115,0.00066325127,0.004910901,0.0000051277652,0.000013350901,0.00027186904,0.00003866012,0.00085861416,0.98945296,0.00003556426,0.003723468,0.000002974231],"about_ca_topic_score_codex":0.00038383514,"about_ca_topic_score_gemma":0.0006833412,"teacher_disagreement_score":0.0011502081,"about_ca_system_score_codex":0.0001421754,"about_ca_system_score_gemma":0.00011563617,"threshold_uncertainty_score":0.003847897},"labels":[],"label_agreement":null},{"id":"W2058582200","doi":"10.1080/07357900600705599","title":"Metronomic Dosing of Chemotherapy: Applications in Pediatric Oncology","year":2006,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian College of Naturopathic Medicine; Hospital for Sick Children","funders":"","keywords":"Medicine; Dosing; Chemotherapy; Oncology; Intensive care medicine; Pediatric oncology; Pediatric cancer; Refractory (planetary science); Clinical trial; Cancer; Internal medicine","score_opus":0.08034483980473799,"score_gpt":0.4158822447315223,"score_spread":0.3355374049267843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058582200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002571345,0.9985696,0.00014009885,0.00011920656,0.000046521036,0.000003966423,0.000005602885,0.0000041023104,0.0008537943],"genre_scores_gemma":[0.0016503705,0.99743986,0.0003442043,0.00010628854,0.000055583474,0.000006009167,0.000011792292,0.0000012431403,0.000384632],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985147,0.000038734943,0.00002133318,0.000026758873,0.0000506842,0.000011063307],"domain_scores_gemma":[0.9997781,0.00012259446,0.00004756348,0.000007303967,0.000031285188,0.000013234418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045153245,0.00048514517,0.0011122173,0.0015580835,0.00019929065,0.0005605309,0.00054557243,0.00078457803,0.0025762317],"category_scores_gemma":[0.00052185287,0.00020548754,0.00040292385,0.0019508721,0.0003714724,0.0009348254,0.0003445783,0.0011602632,0.0008993633],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082369705,0.00005921461,0.00022887981,0.006811716,0.000046057223,0.00025277995,0.000048718226,0.00033735042,0.0023073745,0.0018483473,0.0060589425,0.9819182],"study_design_scores_gemma":[0.000049151826,0.0004075123,0.0029115858,0.00431132,0.00011204216,0.0057015377,0.00010795828,0.0001911302,0.0022824656,0.0019872084,0.98191285,0.000025337364],"about_ca_topic_score_codex":0.0009210219,"about_ca_topic_score_gemma":0.0023684246,"teacher_disagreement_score":0.0025762317,"about_ca_system_score_codex":0.00050062547,"about_ca_system_score_gemma":0.0005695753,"threshold_uncertainty_score":0.008618355},"labels":[],"label_agreement":null},{"id":"W2071750676","doi":"10.3109/07357900009012182","title":"Introduction: Management of Cancer in the Canadian Healthcare System","year":2000,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Health care; Cancer; Healthcare system; Medicine; Internal medicine; Political science","score_opus":0.03743421111468144,"score_gpt":0.24845337335005468,"score_spread":0.21101916223537326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071750676","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007632882,0.4529492,0.0017624027,0.235807,0.16832267,0.00055470585,0.038371686,0.0005186987,0.10095038],"genre_scores_gemma":[0.012257844,0.44804382,0.0041605765,0.16415983,0.14650632,0.0005223987,0.025021065,0.0004514043,0.19887681],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997829,0.00011026614,0.00014178923,0.00013268898,0.00151922,0.00026696434],"domain_scores_gemma":[0.99101263,0.0007056325,0.0004486715,0.00011944684,0.006510869,0.0012027512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002290186,0.0022797459,0.00122401,0.0082645565,0.0019680592,0.002399754,0.0030282193,0.00392421,0.06252842],"category_scores_gemma":[0.0056660576,0.00079062086,0.0014834667,0.010334719,0.001731923,0.0018656026,0.0016454746,0.003958407,0.015144434],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000040503664,0.000004341296,0.00013302945,0.00019338455,0.0000030373333,0.000013103791,0.000025666965,0.00007795475,0.000020649788,0.00034548398,0.9856032,0.013576143],"study_design_scores_gemma":[0.000010593732,0.000014277617,0.007829012,0.0013412324,0.000012058107,0.000080863836,0.00011143724,0.00006104872,0.000031387444,0.00071666297,0.98975885,0.00003264503],"about_ca_topic_score_codex":0.8567452,"about_ca_topic_score_gemma":0.90694547,"teacher_disagreement_score":0.97551703,"about_ca_system_score_codex":0.02448299,"about_ca_system_score_gemma":0.029338941,"threshold_uncertainty_score":0.28819692},"labels":[],"label_agreement":null},{"id":"W2077304538","doi":"10.1081/cnv-120014886","title":"The New Bisphosphonate, Zometa<sup>®</sup>(Zoledronic Acid), Decreases Skeletal Complications in Both Osteolytic and Osteoblastic Lesions: A Comparison to Pamidronate","year":2002,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Bone health and treatments","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Zoledronic acid; Medicine; Placebo; Breast cancer; Bisphosphonate; Prostate cancer; Chemotherapy; Internal medicine; Clinical endpoint; Urology; Hormonal therapy; Metastatic breast cancer; Surgery; Oncology; Gastroenterology; Cancer; Clinical trial; Osteoporosis; Pathology","score_opus":0.08590388979322759,"score_gpt":0.37001901199799103,"score_spread":0.2841151222047634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077304538","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94732434,0.05005561,0.00023035977,0.00030089193,0.00023752125,0.00016142859,0.00036189458,0.000017019462,0.0013110235],"genre_scores_gemma":[0.97370094,0.0227958,0.0006191134,0.00022450234,0.00029352983,0.000091842216,0.00041087836,0.0000067696787,0.0018565239],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996784,0.0001279302,0.00004271737,0.00003551331,0.00008177582,0.00003380679],"domain_scores_gemma":[0.99967206,0.000122935,0.000090297675,0.000011807259,0.000024148034,0.0000786736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058875635,0.00028977048,0.0010505429,0.00043072394,0.00010463094,0.00035976287,0.0003057203,0.0005840968,0.00408999],"category_scores_gemma":[0.0006585766,0.00018286773,0.00095688226,0.00030619025,0.00025512534,0.0004465556,0.0002065934,0.0006921273,0.00030500445],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68973327,0.0067200623,0.006484101,0.0031172696,0.0026962506,0.000107571184,0.00013795668,0.00060514134,0.051707495,0.0004161571,0.001077148,0.23719752],"study_design_scores_gemma":[0.2518828,0.5849496,0.107812345,0.0004256221,0.0062994845,0.0010921346,0.00030930695,0.0017684973,0.02808137,0.0004172591,0.01688918,0.00007243249],"about_ca_topic_score_codex":0.0008466581,"about_ca_topic_score_gemma":0.0024899216,"teacher_disagreement_score":0.00408999,"about_ca_system_score_codex":0.0003439119,"about_ca_system_score_gemma":0.00033409442,"threshold_uncertainty_score":0.013682365},"labels":[],"label_agreement":null},{"id":"W2089602338","doi":"10.3109/07357900009012184","title":"Canadian Healthcare System's Management of Patients with Cancer","year":2000,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Health care; Medicine; Cancer; Healthcare system; Intensive care medicine; Internal medicine; Political science","score_opus":0.023111485446793277,"score_gpt":0.2146812301005449,"score_spread":0.19156974465375162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089602338","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73147666,0.011261439,0.0006412965,0.15147075,0.0006275932,0.00030606438,0.022075428,0.000049405426,0.08209143],"genre_scores_gemma":[0.987444,0.0033637153,0.00042294315,0.0029780522,0.00014310064,0.00002665187,0.0022196562,0.000008668369,0.003393217],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99670804,0.00072555477,0.00019644064,0.0001545561,0.00096058764,0.001254733],"domain_scores_gemma":[0.99108255,0.0010546611,0.0018738484,0.000115912146,0.0029579832,0.0029150678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016395366,0.000248183,0.00031083624,0.0017070547,0.0028310916,0.0031405287,0.0015199251,0.001437268,0.0058175377],"category_scores_gemma":[0.01673418,0.00024257838,0.00072778686,0.0056901653,0.00079565373,0.0006590676,0.0011960332,0.0015490339,0.00020308762],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004397781,0.00030196435,0.74104434,0.00045400264,0.00034125388,0.0007104265,0.002220104,0.012041833,0.00022425773,0.027999384,0.14475907,0.06946349],"study_design_scores_gemma":[0.000090284295,0.00010239863,0.92612576,0.00039680922,0.00014777569,0.00032027005,0.006321208,0.008806684,0.00013201997,0.0022010591,0.055244334,0.000111390145],"about_ca_topic_score_codex":0.9935323,"about_ca_topic_score_gemma":0.99719703,"teacher_disagreement_score":0.90013194,"about_ca_system_score_codex":0.09986809,"about_ca_system_score_gemma":0.12425432,"threshold_uncertainty_score":0.7245971},"labels":[],"label_agreement":null},{"id":"W2089980833","doi":"10.3109/07357907.2011.606250","title":"Two-Year Clinical Experience With Tomotherapy: The French National Cancer Institute Project on Implementing New Technology","year":2011,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Tomotherapy; Medicine; Toxicity; Chronic toxicity; Radiation therapy; Acute toxicity; Cancer; Head and neck cancer; Surgery; Internal medicine","score_opus":0.09731402318494221,"score_gpt":0.4033981589609579,"score_spread":0.3060841357760157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089980833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9075761,0.041732542,0.018889666,0.0040833945,0.00027880011,0.00090470305,0.00059334416,0.0007044598,0.025236972],"genre_scores_gemma":[0.9476717,0.014185213,0.022609942,0.0029647546,0.0004902641,0.00080527883,0.0021686575,0.00039847314,0.008705667],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9919145,0.004775645,0.0003507812,0.0006960946,0.0011639682,0.0010989475],"domain_scores_gemma":[0.9920769,0.002072349,0.0011473908,0.0008994849,0.0017826762,0.0020212235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012386602,0.0013766886,0.00066733704,0.0012311015,0.0014831376,0.0020094947,0.001534383,0.0017815374,0.0034698348],"category_scores_gemma":[0.008872131,0.00038815712,0.0010521996,0.0016070374,0.0008943608,0.001014745,0.001816842,0.0011505148,0.0014109181],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004170889,0.005015617,0.17956816,0.0009308197,0.0005544303,0.0028397078,0.0077273976,0.0056012673,0.019673843,0.0009338414,0.014452817,0.7585312],"study_design_scores_gemma":[0.0017884871,0.048542768,0.60750633,0.0009440236,0.00070684747,0.037642296,0.0044776467,0.003389492,0.032987583,0.00095373055,0.2607245,0.00033627884],"about_ca_topic_score_codex":0.0067829443,"about_ca_topic_score_gemma":0.0069366377,"teacher_disagreement_score":0.012386602,"about_ca_system_score_codex":0.0027960897,"about_ca_system_score_gemma":0.0033556197,"threshold_uncertainty_score":0.06550741},"labels":[],"label_agreement":null},{"id":"W2095581747","doi":"10.1081/cnv-120027578","title":"Action of Troxacitabine on Cells Transduced with Human Cytidine Deaminase cDNA","year":2004,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Cytidine deaminase; Cytidine; Activation-induced (cytidine) deaminase; Complementary DNA; Action (physics); Cytosine deaminase; Molecular biology; Chemistry; Biology; DNA; Genetics; Gene; Enzyme; Biochemistry; Genetic enhancement; Physics; Antibody","score_opus":0.0508670018797453,"score_gpt":0.3002596755784858,"score_spread":0.24939267369874052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095581747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996507,0.0008218222,0.0006040446,0.00006163987,0.00004410478,0.000030078283,0.00024343125,0.00002040621,0.0016675406],"genre_scores_gemma":[0.9947699,0.00078448147,0.0016369126,0.0000367022,0.0000089195955,0.00002836083,0.0006339812,0.00001211056,0.0020886713],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983394,0.00003465398,0.00001919719,0.000038521594,0.000043820106,0.000029828789],"domain_scores_gemma":[0.99988914,0.000043353266,0.000018549008,0.000023874205,0.000010645137,0.000014381788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014687037,0.00022996211,0.00024080604,0.00011355715,0.00013748252,0.00031090915,0.00013870053,0.00022352269,0.0014123558],"category_scores_gemma":[0.000120443314,0.00012219335,0.00020672384,0.00013597874,0.0001951956,0.00017106238,0.00009293717,0.00053414167,0.00030672608],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009793554,0.00006294753,0.00009833067,0.000017409577,0.0000034931204,0.00004312414,0.000018354503,0.000069025045,0.9985708,0.00011192156,0.00003680346,0.00086990825],"study_design_scores_gemma":[0.000029786937,0.0008235197,0.001456376,0.000004327657,0.000009640274,0.00013943632,0.000021476773,0.00086426357,0.9954163,0.000016485496,0.0012157771,0.0000026689088],"about_ca_topic_score_codex":0.0009763686,"about_ca_topic_score_gemma":0.00083121134,"teacher_disagreement_score":0.0014123558,"about_ca_system_score_codex":0.00036295323,"about_ca_system_score_gemma":0.00018142952,"threshold_uncertainty_score":0.0047248006},"labels":[],"label_agreement":null},{"id":"W2097919720","doi":"10.3109/07357907.2014.880452","title":"Association of Aromatase Inhibitors With Coronary Heart Disease in Women With Early Breast Cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Coronary artery disease; Breast cancer; Tamoxifen; Internal medicine; Hazard ratio; Oncology; Aromatase; Population; Cardiology; Letrozole; Aromatase inhibitor; Hormonal therapy; Cancer; Confidence interval","score_opus":0.0034291750784833327,"score_gpt":0.20588743443224386,"score_spread":0.20245825935376052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097919720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99840826,0.0010649873,0.0000643158,0.00006226458,0.0000052998685,0.0000037299155,0.00007209158,0.0000013057894,0.0003177331],"genre_scores_gemma":[0.9993818,0.00036561664,0.000041717114,0.000027089543,0.000013142832,0.0000021336816,0.000048555798,5.4920474e-7,0.00011938433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996574,0.00015083337,0.000029053199,0.000047774436,0.00006809525,0.000046830384],"domain_scores_gemma":[0.99899095,0.00039437856,0.00035227038,0.00007260766,0.00007481032,0.00011500396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048518612,0.00012631693,0.00027313095,0.00028568975,0.00018176525,0.00034908514,0.00013990435,0.00028210992,0.00063798606],"category_scores_gemma":[0.002338758,0.00015306185,0.00028660725,0.00041943535,0.0001517435,0.00014425188,0.00014532018,0.0004539421,0.000070431284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051985227,0.00005614214,0.9965077,0.000011121653,0.00010401146,0.00010309717,0.00002107681,0.000026046126,0.00063300837,0.0000137816505,0.000029403041,0.001974763],"study_design_scores_gemma":[0.00001812607,0.00015031447,0.99926144,0.0000021130102,0.000075198,0.00017906877,0.000026044525,0.0000660159,0.00010577024,0.000018697228,0.00009590475,0.0000013150619],"about_ca_topic_score_codex":0.0024349077,"about_ca_topic_score_gemma":0.0043735346,"teacher_disagreement_score":0.0024349077,"about_ca_system_score_codex":0.00013052924,"about_ca_system_score_gemma":0.0001899578,"threshold_uncertainty_score":0.004841447},"labels":[],"label_agreement":null},{"id":"W2100197588","doi":"10.1081/cnv-120002497","title":"Defining Clinically Meaningful Outcomes in the Evaluation of New Treatments for Oral Mucositis: Oral Mucositis Patient Provider Advisory Board","year":2002,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mucositis; Medicine; Clinical trial; Oral mucosa; Intensive care medicine; Quality of life (healthcare); Oral medicine; Patient-reported outcome; Internal medicine; Dentistry; Chemotherapy; Pathology","score_opus":0.21753816875662835,"score_gpt":0.433815753166602,"score_spread":0.21627758440997363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100197588","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04728428,0.015051283,0.02589918,0.8151032,0.012183142,0.008807081,0.0009338583,0.0003287606,0.074409276],"genre_scores_gemma":[0.47595754,0.016319517,0.14056216,0.30596188,0.019877853,0.015719319,0.0019985882,0.00022463853,0.023378508],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.93603486,0.048375916,0.0070511424,0.00067776645,0.0066771284,0.0011832131],"domain_scores_gemma":[0.84277016,0.06600588,0.019410565,0.0050453222,0.052347723,0.014420351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10223081,0.00047259917,0.0009962047,0.0008625042,0.0019045849,0.0028975948,0.0011475792,0.005652504,0.004616568],"category_scores_gemma":[0.12589864,0.0003567939,0.0006643314,0.0009490064,0.0013050155,0.0015374392,0.0020536468,0.008817959,0.0021813263],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017907411,0.0012200986,0.035638385,0.0012806616,0.000104000195,0.00059637456,0.0014575195,0.0006384052,0.0035218582,0.009440382,0.55464983,0.38966182],"study_design_scores_gemma":[0.0026693295,0.0031775679,0.087634034,0.004037244,0.00020341369,0.0017442016,0.0018533211,0.0054840655,0.0041454206,0.010793653,0.8780495,0.00020831775],"about_ca_topic_score_codex":0.000812353,"about_ca_topic_score_gemma":0.0020892513,"teacher_disagreement_score":0.10223081,"about_ca_system_score_codex":0.0019163697,"about_ca_system_score_gemma":0.00978019,"threshold_uncertainty_score":0.54065466},"labels":[],"label_agreement":null},{"id":"W2101857408","doi":"10.1081/cnv-100102548","title":"Mitoxantrone and Paclitaxel Combination Chemotherapy in Metastatic Breast Cancer","year":2001,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"Bristol-Myers Squibb","keywords":"Mitoxantrone; Medicine; Chemotherapy; Cardiotoxicity; Metastatic breast cancer; Internal medicine; Neutropenia; Regimen; Oncology; Breast cancer; Nausea; Doxorubicin; Paclitaxel; Cancer; Progressive disease; Surgery","score_opus":0.03761453095331926,"score_gpt":0.3490888451618517,"score_spread":0.31147431420853244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101857408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98822814,0.009555931,0.00035533705,0.00021966087,0.00004498708,0.00011846336,0.000047508845,0.000012675207,0.0014171908],"genre_scores_gemma":[0.9925368,0.0054845056,0.00078658655,0.00012545366,0.00010024278,0.00008221797,0.00018852054,0.0000028550166,0.0006928853],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99974376,0.0001208373,0.000018066701,0.000018263376,0.000056942485,0.000042039646],"domain_scores_gemma":[0.9998789,0.000035107143,0.000027978647,0.0000053967933,0.000010608322,0.000042037907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031687797,0.00019605474,0.00040310383,0.00025183833,0.00025271095,0.00017417873,0.00012331294,0.00017116271,0.0007553192],"category_scores_gemma":[0.0005346434,0.000104198436,0.00021383168,0.00027742036,0.00013657808,0.00014490038,0.00012854002,0.0003128126,0.00014717403],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028627045,0.0051628766,0.13574933,0.00081889227,0.0007045377,0.0034411743,0.0004720498,0.004562408,0.08498393,0.00044572956,0.002530174,0.7325018],"study_design_scores_gemma":[0.022867493,0.2477097,0.59042436,0.00025743898,0.001711555,0.023327693,0.000348087,0.005834908,0.03777799,0.0006604582,0.06900564,0.00007457798],"about_ca_topic_score_codex":0.0005918248,"about_ca_topic_score_gemma":0.0032656328,"teacher_disagreement_score":0.0007553192,"about_ca_system_score_codex":0.00031353274,"about_ca_system_score_gemma":0.0002902848,"threshold_uncertainty_score":0.00252676},"labels":[],"label_agreement":null},{"id":"W2101868054","doi":"10.1081/cnv-100103843","title":"Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Etoposide (CHOPE) for Advanced-Stage Hodgkin's Disease: CALGB 8856","year":2001,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care","funders":"National Cancer Institute","keywords":"Vincristine; Medicine; Procarbazine; Etoposide; Dacarbazine; Prednisone; ABVD; Internal medicine; Vinblastine; Regimen; Cyclophosphamide; Surgery; Gastroenterology; Cohort; Chemotherapy; Oncology; Urology","score_opus":0.025525111102034332,"score_gpt":0.30861721996975455,"score_spread":0.28309210886772024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101868054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203086,0.0030286333,0.0004617806,0.00031136945,0.000026960619,0.0005225992,0.00056949817,0.000054844415,0.002993506],"genre_scores_gemma":[0.9857458,0.0032820934,0.0036726887,0.0005289095,0.000085573665,0.00039894343,0.0028928968,0.000017799544,0.0033752646],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998197,0.00004325065,0.000013792463,0.00004110144,0.000035054647,0.00004713337],"domain_scores_gemma":[0.9998043,0.000022209975,0.000015217179,0.000017349914,0.000011429108,0.00012947302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056746387,0.00054664235,0.0007617648,0.00037722342,0.0006163988,0.00043267047,0.000504955,0.00031328655,0.0035352863],"category_scores_gemma":[0.00031509486,0.00032200917,0.00029785876,0.00048576758,0.00042287237,0.00017235597,0.0005048395,0.0008711519,0.00072575617],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08045611,0.011633297,0.18952566,0.0013647445,0.0008558759,0.003235104,0.00072398025,0.0046392195,0.17796373,0.0007776284,0.01756797,0.5112568],"study_design_scores_gemma":[0.060303196,0.065007314,0.7797792,0.0002091016,0.0009518429,0.009533796,0.00023321077,0.0043220865,0.01815179,0.00035483108,0.061056953,0.00009655735],"about_ca_topic_score_codex":0.0080879405,"about_ca_topic_score_gemma":0.01683671,"teacher_disagreement_score":0.0080879405,"about_ca_system_score_codex":0.0008170377,"about_ca_system_score_gemma":0.0009957806,"threshold_uncertainty_score":0.01608169},"labels":[],"label_agreement":null},{"id":"W2101907056","doi":"10.1081/cnv-120001183","title":"Applications of SKY in Cancer Cytogenetics","year":2002,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Cytogenetics; Fluorescence in situ hybridization; Molecular cytogenetics; Biology; Karyotype; Cancer; Computational biology; Pathology; Chromosome; Genetics; Gene; Medicine","score_opus":0.05758597888379116,"score_gpt":0.3281223273917117,"score_spread":0.2705363485079205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101907056","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021391602,0.994453,0.0010847558,0.0005104071,0.00044398487,0.000009029773,0.000014308345,0.000022456774,0.0032481544],"genre_scores_gemma":[0.0012461105,0.9951546,0.0013897564,0.0003836792,0.00026123857,0.000012723091,0.00003618848,0.0000050010713,0.0015107633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99941456,0.00013509314,0.0000625303,0.00010012823,0.00025499848,0.000032708256],"domain_scores_gemma":[0.9992607,0.00036188663,0.000048353257,0.000038887036,0.0002457366,0.00004436958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012703225,0.00094808463,0.0014881032,0.004502208,0.00048526935,0.001194494,0.00091004133,0.001434971,0.0025168532],"category_scores_gemma":[0.0013247525,0.00041963052,0.0006279411,0.003545226,0.0012945129,0.0020393624,0.0009480778,0.0024070607,0.0028614728],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059493468,0.000042931097,0.00047530662,0.008716705,0.000067811096,0.0008229084,0.00016667273,0.00065884105,0.006708944,0.010014102,0.025256203,0.9470102],"study_design_scores_gemma":[0.000009143956,0.000044221477,0.0009626389,0.00080953236,0.000032606935,0.0033423782,0.00008506145,0.00008820151,0.0015962756,0.0037672126,0.9892385,0.000024334935],"about_ca_topic_score_codex":0.0017979856,"about_ca_topic_score_gemma":0.002474442,"teacher_disagreement_score":0.004502208,"about_ca_system_score_codex":0.0012342229,"about_ca_system_score_gemma":0.0009870167,"threshold_uncertainty_score":0.008954942},"labels":[],"label_agreement":null},{"id":"W2103523021","doi":"10.3109/07357907.2014.958232","title":"Increased Expression of Tumor Proliferation Genes in Hispanic Women with Early-Stage Breast Cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute; National Institutes of Health; National Center for Advancing Translational Sciences; Genomic Health","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Oncology; Internal medicine; Cancer; Gynecology; Biology","score_opus":0.00984091592139721,"score_gpt":0.23602048796443184,"score_spread":0.22617957204303463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103523021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995535,0.00013072114,0.000022324799,0.000011630765,0.0000012902026,0.000001020356,0.0000392778,7.2208076e-7,0.00023947962],"genre_scores_gemma":[0.99945825,0.00015738819,0.00003411281,0.00001155186,0.0000039300153,0.000002362388,0.00008859454,8.9124774e-7,0.00024295089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999615,0.000012753324,0.0000020276666,0.0000068965087,0.000008033807,0.0000088054385],"domain_scores_gemma":[0.99989796,0.000020438756,0.000045756522,0.0000058766127,0.000012273965,0.000017670784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118860145,0.000080298836,0.00007437076,0.00035740956,0.00013059535,0.00020791857,0.00004666701,0.0000691161,0.0011054302],"category_scores_gemma":[0.00027808026,0.000064871834,0.00007811148,0.00031341228,0.00009937801,0.00007028677,0.00009442344,0.00012041861,0.00009025319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003991557,0.00004801356,0.9849059,0.000012607417,0.000037177877,0.00017881751,0.000115329356,0.000027763512,0.009936533,0.000038227437,0.000067988214,0.0042325845],"study_design_scores_gemma":[0.0000070187325,0.000080143946,0.9979387,0.0000032168505,0.000017413928,0.00030178702,0.00027125486,0.00004021882,0.0010292671,0.000027495913,0.00028240413,0.0000010502933],"about_ca_topic_score_codex":0.0015694892,"about_ca_topic_score_gemma":0.0016970509,"teacher_disagreement_score":0.0015694892,"about_ca_system_score_codex":0.000091353206,"about_ca_system_score_gemma":0.00009148082,"threshold_uncertainty_score":0.003698051},"labels":[],"label_agreement":null},{"id":"W2120007701","doi":"10.1080/07357900701560612","title":"Serum Vascular Endothelial Growth Factor (VEGF) Levels Correlate with Tumor VEGF and p53 Overexpression in Endocrine Positive Primary Breast Cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Polytechnique Montréal","funders":"","keywords":"Vascular endothelial growth factor; Angiogenesis; Breast cancer; Medicine; Internal medicine; Endocrine system; Immunohistochemistry; Cancer; Basal (medicine); Microvessel; Neovascularization; Endocrinology; Pathology; Oncology; VEGF receptors; Hormone","score_opus":0.01540441150640647,"score_gpt":0.23601022091869628,"score_spread":0.2206058094122898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120007701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99953365,0.00025001745,0.000060278857,0.000012948975,0.0000024743856,0.0000017091955,0.000025050063,0.0000034486648,0.00011040207],"genre_scores_gemma":[0.9997372,0.000083611725,0.000052195246,0.000008096792,0.000005127958,0.0000024361343,0.000039706345,6.4527984e-7,0.00007106932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985933,0.000037081434,0.000018885703,0.000029165292,0.000027894845,0.000027677392],"domain_scores_gemma":[0.9993801,0.0002037557,0.00020186776,0.0000269336,0.00005961796,0.0001277388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020286563,0.00023775584,0.00025480398,0.0005915716,0.00019844003,0.00031348373,0.00009066319,0.00026573704,0.0009698462],"category_scores_gemma":[0.0011697208,0.0001929271,0.00011994715,0.00037723655,0.00027798855,0.00015660739,0.00016332355,0.00026484014,0.00021368085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054074725,0.000053930522,0.9832187,0.000023764635,0.000044662927,0.00052434794,0.000062641935,0.00007139307,0.012570461,0.000015089336,0.00006677859,0.002807485],"study_design_scores_gemma":[0.000018132638,0.0002821965,0.99424696,0.0000035193113,0.000045254554,0.0028394829,0.00008130081,0.00017727644,0.0021296008,0.000028126968,0.0001448737,0.0000032512257],"about_ca_topic_score_codex":0.000475524,"about_ca_topic_score_gemma":0.00061385205,"teacher_disagreement_score":0.0009698462,"about_ca_system_score_codex":0.00018082367,"about_ca_system_score_gemma":0.000117587064,"threshold_uncertainty_score":0.0032445192},"labels":[],"label_agreement":null},{"id":"W2135706959","doi":"10.1080/07357900902996441","title":"Cancer and Thrombosis: Back to the Future<i>Renewed Interest in an Old Problem</i>","year":2009,"lang":"en","type":"letter","venue":"Cancer Investigation","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cancer; Thrombosis; Ambulatory; Randomized controlled trial; Venous thromboembolism; Metastasis; Intensive care medicine; Surgery; Internal medicine; Oncology","score_opus":0.06534462197541314,"score_gpt":0.31311535374578825,"score_spread":0.24777073177037512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135706959","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060475105,0.01500125,0.00009301882,0.970524,0.011354394,0.0000070118226,0.000014989215,0.00001624061,0.002384394],"genre_scores_gemma":[0.00839703,0.030586073,0.0004321118,0.8014891,0.15456504,0.000025640444,0.0000260122,0.000014131236,0.0044648675],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974437,0.0012600458,0.00025938815,0.00027923405,0.00057447155,0.00018333338],"domain_scores_gemma":[0.99272114,0.0045386064,0.00051466067,0.00020952463,0.0011980218,0.0008180538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002407583,0.00075144065,0.001586922,0.0007083741,0.0016614461,0.0031266583,0.0010532958,0.027805636,0.0055467337],"category_scores_gemma":[0.013109471,0.00044315887,0.000902132,0.00082541956,0.003876667,0.004999814,0.00072721345,0.021973366,0.0041333535],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015636475,0.000099723795,0.002247271,0.00045895256,0.000038594113,0.011340839,0.00023053259,0.00014295867,0.0004278031,0.006360849,0.92029303,0.058203075],"study_design_scores_gemma":[0.00036573876,0.00034580918,0.0044966326,0.0022962587,0.000082011255,0.053093106,0.0014884279,0.00072484923,0.00026523467,0.03079417,0.9059468,0.00010092714],"about_ca_topic_score_codex":0.0017169864,"about_ca_topic_score_gemma":0.002498221,"teacher_disagreement_score":0.027805636,"about_ca_system_score_codex":0.0037957518,"about_ca_system_score_gemma":0.0017277111,"threshold_uncertainty_score":0.027540267},"labels":[],"label_agreement":null},{"id":"W2138581078","doi":"10.3109/07357907.2014.889706","title":"Presurgical Trial of Metformin in Overweight and Obese Patients with Newly Diagnosed Breast Cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Medicine; Metformin; Overweight; Breast cancer; Cancer; Obesity; Internal medicine; Oncology; Clinical trial; Gynecology; Insulin","score_opus":0.007382633654831579,"score_gpt":0.2316883924968264,"score_spread":0.22430575884199483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138581078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99781775,0.0011013274,0.000051262436,0.00015410552,0.000047629346,0.00027405686,0.000096595,0.000008587279,0.00044866157],"genre_scores_gemma":[0.99701536,0.00080055447,0.00028802143,0.00040827572,0.00015646628,0.00044271233,0.000342936,0.0000023349166,0.0005434371],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99973124,0.00012097057,0.000019341636,0.000037962232,0.000039537656,0.000050951912],"domain_scores_gemma":[0.99945635,0.0000987554,0.00011083098,0.000024249523,0.000031017327,0.00027891804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000635986,0.00067869737,0.0012298902,0.00029282822,0.00046150445,0.0005252843,0.0003683267,0.0007477269,0.002969334],"category_scores_gemma":[0.00070986996,0.00025212351,0.0006508677,0.0002728543,0.00044920362,0.0002991913,0.0003096717,0.0014338946,0.00026208186],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90326494,0.021246526,0.020902803,0.00036537493,0.00072549813,0.00021416815,0.00007227097,0.00029443263,0.009481159,0.00006370839,0.0006434383,0.042725675],"study_design_scores_gemma":[0.32039613,0.58475536,0.08705071,0.000047376467,0.0008610569,0.00023855794,0.00009196018,0.0005488277,0.00377716,0.00010004073,0.0021053178,0.00002757945],"about_ca_topic_score_codex":0.0007649161,"about_ca_topic_score_gemma":0.0029244286,"teacher_disagreement_score":0.002969334,"about_ca_system_score_codex":0.0004819048,"about_ca_system_score_gemma":0.0009796806,"threshold_uncertainty_score":0.0099333525},"labels":[],"label_agreement":null},{"id":"W2143264131","doi":"10.3109/07357907.2010.512597","title":"Clinical Significance of GPR56, Transglutaminase 2, and NF-κB in Esophageal Squamous Cell Carcinoma","year":2010,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Blood properties and coagulation","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Council of Scientific and Industrial Research, India; Department of Science and Technology, Ministry of Science and Technology, India","keywords":"Tissue transglutaminase; Tissue microarray; Immunostaining; Immunohistochemistry; Pathology; Esophageal squamous cell carcinoma; Cancer research; Metastasis; Biology; Carcinoma; Medicine; Cancer; Internal medicine; Enzyme","score_opus":0.03536236357715308,"score_gpt":0.29608232036733617,"score_spread":0.2607199567901831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143264131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942107,0.0032946814,0.00032452776,0.00020192207,0.000014318399,0.000015253852,0.000050060073,0.000009864287,0.0018786661],"genre_scores_gemma":[0.99931765,0.00030436926,0.00014656398,0.000025523002,0.000020230891,0.0000032698833,0.000027805329,8.5641216e-7,0.00015366849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998561,0.00004365748,0.000020436282,0.000026955448,0.000031401523,0.000021546392],"domain_scores_gemma":[0.99977607,0.00006149674,0.00006457914,0.000016356855,0.000026165839,0.00005525258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037419316,0.00021186515,0.00028062536,0.00034365235,0.0001930421,0.000269034,0.0001446523,0.00029431304,0.0010650099],"category_scores_gemma":[0.00089115265,0.00010746079,0.00015085742,0.00028944193,0.0004252886,0.00027348063,0.00014615327,0.00029102855,0.0002162119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031350423,0.00012593043,0.86157006,0.00018034333,0.00009158637,0.026752671,0.00013300852,0.0002797672,0.07590537,0.00037180277,0.00046699404,0.030987397],"study_design_scores_gemma":[0.000110387715,0.0008363747,0.9262431,0.00003223603,0.00016543936,0.055252943,0.00025739498,0.001556842,0.012403813,0.00055734604,0.0025674482,0.000016717071],"about_ca_topic_score_codex":0.0002910219,"about_ca_topic_score_gemma":0.00043664064,"teacher_disagreement_score":0.0010650099,"about_ca_system_score_codex":0.00020568611,"about_ca_system_score_gemma":0.00014631168,"threshold_uncertainty_score":0.003562808},"labels":[],"label_agreement":null},{"id":"W2156495442","doi":"10.1081/cnv-120005901","title":"Low Molecular Weight Heparin for Venous Thromboembolism Prophylaxis in Urologic Oncologic Surgery","year":2002,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Hematocrit; Low molecular weight heparin; Surgery; Venous thrombosis; Prospective cohort study; Anesthesia; Thrombosis; Internal medicine","score_opus":0.050237268664268565,"score_gpt":0.2820849420657845,"score_spread":0.23184767340151594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156495442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853826,0.0010400784,0.00004997642,0.000051527793,0.000010564234,0.000019655312,0.000040423998,0.0000016515552,0.000247999],"genre_scores_gemma":[0.9989033,0.0005295179,0.00014116889,0.000097299344,0.00004702442,0.000022171283,0.00010527402,0.0000010578678,0.00015310531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999305,0.00028357725,0.00008512251,0.00005914579,0.00016394748,0.00010320335],"domain_scores_gemma":[0.9981812,0.0005506584,0.00067620643,0.000049111644,0.00013087662,0.0004118834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058119325,0.00020446227,0.00029456592,0.0002525686,0.0003203154,0.0005043165,0.00016464778,0.00037341026,0.0017108545],"category_scores_gemma":[0.0027671827,0.00012887506,0.00026305893,0.00035650848,0.00014815232,0.00025195145,0.0001582985,0.00039293154,0.0002604597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001220635,0.0005500713,0.9869826,0.000058039743,0.000081327686,0.00017638209,0.00005020574,0.000041060175,0.00062294665,0.000012821629,0.000107173226,0.010096723],"study_design_scores_gemma":[0.00032190944,0.012647568,0.98161685,0.00004649342,0.0001371688,0.0028207314,0.0001668123,0.00025413893,0.00058043585,0.000025230735,0.0013738791,0.000008730108],"about_ca_topic_score_codex":0.00029014674,"about_ca_topic_score_gemma":0.0005261339,"teacher_disagreement_score":0.0017108545,"about_ca_system_score_codex":0.00011894598,"about_ca_system_score_gemma":0.000499576,"threshold_uncertainty_score":0.005723417},"labels":[],"label_agreement":null},{"id":"W2157925255","doi":"10.3109/07357900903287030","title":"Interleukin-17F Suppresses Hepatocarcinoma Cell Growth via Inhibition of Tumor Angiogenesis","year":2010,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Angiogenesis; In vivo; Cancer research; Cell growth; Vascular endothelial growth factor; Cell; In vitro; Hepatocellular carcinoma; Biology; Interleukin 8; Microvessel; Interleukin; Transfection; Cell culture; Molecular biology; Immunology; Cytokine; VEGF receptors","score_opus":0.01184721748998662,"score_gpt":0.2349356368205134,"score_spread":0.22308841933052678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157925255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950664,0.0020332616,0.0011568638,0.00008309951,0.000040319963,0.000034519308,0.00021822723,0.00008539318,0.0012818968],"genre_scores_gemma":[0.99519736,0.0015778242,0.0010838603,0.000048363607,0.000018663159,0.000052965024,0.00035704102,0.0000136160415,0.0016503963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986744,0.000028809469,0.00001433697,0.000011940161,0.000034228608,0.00004327817],"domain_scores_gemma":[0.9998977,0.000022025244,0.000028852133,0.000013597392,0.000011420413,0.000026348702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000155256,0.00035557995,0.00029351554,0.00028616382,0.00010352683,0.00016517391,0.00010564987,0.00015519162,0.0007635218],"category_scores_gemma":[0.00009644715,0.00008814551,0.00028548882,0.00013593597,0.00017273026,0.00009686938,0.00012834063,0.0005088436,0.00020133215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022171855,0.00011979016,0.0004648717,0.000056540684,0.000007078712,0.00009419705,0.000026672013,0.00009769624,0.99652416,0.00007259352,0.00007342443,0.0022411912],"study_design_scores_gemma":[0.00008424042,0.001221592,0.006034262,0.000010908524,0.000023238163,0.00032681596,0.00004444644,0.001580994,0.98723084,0.000049885293,0.0033880873,0.0000048221104],"about_ca_topic_score_codex":0.00076291454,"about_ca_topic_score_gemma":0.0008073147,"teacher_disagreement_score":0.0007635218,"about_ca_system_score_codex":0.00017534803,"about_ca_system_score_gemma":0.00023516049,"threshold_uncertainty_score":0.0025542974},"labels":[],"label_agreement":null},{"id":"W2160584144","doi":"10.3109/07357900009012183","title":"Cancer Care in Ontario: Accessible Oncology on Sale, or Cheque's in the Mail?","year":2000,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Cheque; Medicine; Oncology; Family medicine; World Wide Web; Internal medicine; Computer science","score_opus":0.054360956730287784,"score_gpt":0.4205797911907594,"score_spread":0.3662188344604716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160584144","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44824156,0.012857809,0.00022628074,0.3423292,0.0014141867,0.0003801911,0.0107153775,0.00013077524,0.18370458],"genre_scores_gemma":[0.800398,0.01166258,0.000765778,0.045532864,0.00078259635,0.00013908955,0.0026128795,0.00008227528,0.1380239],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990055,0.00010674654,0.000054159438,0.00006141354,0.00031242432,0.00045984713],"domain_scores_gemma":[0.9953564,0.00030698627,0.00082747405,0.00008016376,0.0012360461,0.0021929268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005235062,0.00016914008,0.00020498637,0.00093923305,0.0052950215,0.0023664932,0.0008192284,0.0019592992,0.035106756],"category_scores_gemma":[0.0029596696,0.00026908098,0.00025981187,0.0028985925,0.0018616705,0.0014246751,0.001397872,0.0016186261,0.0017834429],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039495248,0.00025413852,0.583854,0.00071196374,0.000034244138,0.0020117015,0.008577384,0.00009226979,0.00081303774,0.0057516294,0.32677278,0.07073186],"study_design_scores_gemma":[0.00007330351,0.00010038684,0.7669802,0.0004979958,0.000041428888,0.00038834233,0.026607364,0.00016416617,0.00015037978,0.000649693,0.20430581,0.000040811534],"about_ca_topic_score_codex":0.9807782,"about_ca_topic_score_gemma":0.99599564,"teacher_disagreement_score":0.95279175,"about_ca_system_score_codex":0.047208257,"about_ca_system_score_gemma":0.09555951,"threshold_uncertainty_score":0.3425215},"labels":[],"label_agreement":null},{"id":"W2167810032","doi":"10.3109/07357900009031830","title":"Telomerase: Therapeutic Potential in Cancer","year":2000,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Telomerase; Cancer research; Medicine; Cancer; Telomere; Biology; Internal medicine; DNA; Genetics","score_opus":0.10807540078307784,"score_gpt":0.39189335267132314,"score_spread":0.2838179518882453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167810032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006132787,0.9985676,0.000110250556,0.00026883115,0.00032126,0.0000031316117,0.0000055324776,0.000005034674,0.0006570262],"genre_scores_gemma":[0.00043057973,0.9979518,0.00020559663,0.00029283325,0.00041135564,0.000007111225,0.000012810671,0.0000010072855,0.000686882],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974376,0.000056350946,0.00003697831,0.00004359778,0.00009638723,0.000022903472],"domain_scores_gemma":[0.9994972,0.00027686043,0.00005315857,0.000018183142,0.000100434714,0.000054138163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001381912,0.0013259534,0.0022796916,0.0024163774,0.0005125651,0.0015222484,0.001043725,0.0019798505,0.0031279842],"category_scores_gemma":[0.001179828,0.00035881734,0.0004877346,0.002802255,0.0010410899,0.002318812,0.0009617263,0.0030146714,0.002363949],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016808703,0.00009482456,0.00019402223,0.0088289585,0.0000695221,0.0003445717,0.00007919663,0.00040282225,0.002105727,0.005165496,0.04340048,0.9391462],"study_design_scores_gemma":[0.00005311961,0.000104686995,0.00054493546,0.0024332553,0.00009134288,0.0012394262,0.000088166125,0.00009538179,0.0003386172,0.002605207,0.99238914,0.000016779511],"about_ca_topic_score_codex":0.0010145478,"about_ca_topic_score_gemma":0.00245862,"teacher_disagreement_score":0.0031279842,"about_ca_system_score_codex":0.00084738934,"about_ca_system_score_gemma":0.0012609552,"threshold_uncertainty_score":0.010464191},"labels":[],"label_agreement":null},{"id":"W2168503278","doi":"10.1080/07357900601063766","title":"A Systematic Review on Drug Interactions in Oncology","year":2006,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Drug; Oncology; Clinical Oncology; Internal medicine; Pharmacology; Medical physics; Cancer","score_opus":0.1370314656954665,"score_gpt":0.47981807028664536,"score_spread":0.3427866045911788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168503278","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005175901,0.99808335,0.00013148967,0.0002624961,0.00014719038,0.0002398052,0.00026142807,0.0000065638765,0.0003502083],"genre_scores_gemma":[0.0052190167,0.9923294,0.001082781,0.00044411694,0.000116286195,0.00040914986,0.00019387827,0.0000027324118,0.00020269498],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9938392,0.0025536995,0.0019339347,0.00033200206,0.001188953,0.00015225564],"domain_scores_gemma":[0.9804419,0.013412167,0.0038147888,0.00019121042,0.0018663601,0.0002736271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049847453,0.0015019809,0.0073758694,0.013113753,0.00057775,0.0015986231,0.0015173149,0.0017403723,0.00665056],"category_scores_gemma":[0.027329559,0.0008262643,0.0030971607,0.014692344,0.00060443627,0.0020317642,0.0010146091,0.000901588,0.0006046664],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016608839,0.000020374575,0.0006484484,0.9128101,0.0043154866,0.0003199191,0.000117874304,0.00013751876,0.00020570803,0.00024519317,0.0061053787,0.07490779],"study_design_scores_gemma":[0.0004225834,0.00034880012,0.0065098726,0.8643997,0.04494847,0.00147862,0.00025000636,0.00012738633,0.00025848913,0.0005340735,0.08067778,0.0000443472],"about_ca_topic_score_codex":0.0058348333,"about_ca_topic_score_gemma":0.02605068,"teacher_disagreement_score":0.013113753,"about_ca_system_score_codex":0.0026301048,"about_ca_system_score_gemma":0.010422611,"threshold_uncertainty_score":0.02636218},"labels":[],"label_agreement":null},{"id":"W2171535564","doi":"10.1080/07357900902849681","title":"Specific Reduction of Fas-Associated Protein with Death Domain (FADD) in Clear Cell Renal Cell Carcinoma","year":2009,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"FADD; Cancer research; Apoptosis; Clear cell renal cell carcinoma; Death domain; Carcinogenesis; Kidney; Programmed cell death; Medicine; Renal cell carcinoma; Kidney cancer; Biology; Cancer; Pathology; Internal medicine; Caspase; Biochemistry","score_opus":0.012294689211167576,"score_gpt":0.2108930285530206,"score_spread":0.19859833934185303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171535564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971089,0.0015339224,0.00075265684,0.000025343126,0.00001342872,0.000016614451,0.00007261381,0.0000161492,0.00046030775],"genre_scores_gemma":[0.99820614,0.00047368632,0.0005772013,0.000018679228,0.0000035313683,0.0000106001025,0.00014007857,0.0000035844282,0.00056644896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988127,0.00001825589,0.000010768521,0.000022636339,0.0000405037,0.000026569462],"domain_scores_gemma":[0.9999329,0.000012631578,0.000011503048,0.000011515,0.0000121476005,0.000019218161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018000054,0.00013115305,0.00025889007,0.0003231104,0.00013735202,0.0001619661,0.00013320034,0.00021586935,0.0006956626],"category_scores_gemma":[0.00016525584,0.000118393764,0.00016012845,0.00018469225,0.00020711368,0.00011005451,0.00010955548,0.00021091424,0.00017509358],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024008684,0.00004772646,0.0010792806,0.000031980362,0.000011165272,0.00012940305,0.00001564767,0.00006955061,0.99617934,0.00007510223,0.000040507388,0.0020801695],"study_design_scores_gemma":[0.000097073265,0.0017280221,0.029067108,0.0000040611503,0.000053830216,0.002279915,0.000039416733,0.0010532808,0.96328884,0.000078136814,0.0023025172,0.0000078753055],"about_ca_topic_score_codex":0.0012555592,"about_ca_topic_score_gemma":0.0014719014,"teacher_disagreement_score":0.0012555592,"about_ca_system_score_codex":0.00026178043,"about_ca_system_score_gemma":0.0002386079,"threshold_uncertainty_score":0.0024965405},"labels":[],"label_agreement":null},{"id":"W2263421483","doi":"10.3109/07357907.2015.1088948","title":"Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent Glioblastoma","year":2016,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Bevacizumab; Glioblastoma; Angiopoietin 2; Medicine; Biomarker; Oncology; Internal medicine; VEGF receptors; Angiopoietin receptor; Chemotherapy; Vascular endothelial growth factor; Cancer research; Chemistry","score_opus":0.029195824880419448,"score_gpt":0.28969299656514963,"score_spread":0.2604971716847302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2263421483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99852353,0.0009881286,0.00012303382,0.00006462204,0.000004071805,0.000006375911,0.000020528687,0.0000058552355,0.00026389802],"genre_scores_gemma":[0.9994111,0.0002759141,0.00008765785,0.000025706238,0.000008460993,0.000004610031,0.000027587685,0.0000011410659,0.00015780082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999429,0.000017119864,0.000006197448,0.000008349366,0.000010765806,0.0000146649445],"domain_scores_gemma":[0.99984574,0.000028067378,0.000081156424,0.0000070114934,0.000013800809,0.000024173105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022068378,0.00013960812,0.00022576156,0.00033643376,0.00009725812,0.00029913968,0.00010727313,0.00022143454,0.00051208655],"category_scores_gemma":[0.00046141804,0.000110036155,0.00015370053,0.00022113073,0.00016727063,0.00016986948,0.00008907438,0.0003040191,0.00008174352],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010687993,0.0004639907,0.34137028,0.00021775508,0.00018774866,0.0069244513,0.00044908005,0.0013741009,0.57180774,0.0008935624,0.00074947637,0.064873844],"study_design_scores_gemma":[0.00028931606,0.0028424885,0.90645,0.000025035077,0.00025401922,0.007881676,0.00023874528,0.0071766633,0.07048464,0.0009476583,0.003382849,0.000027000071],"about_ca_topic_score_codex":0.00063048827,"about_ca_topic_score_gemma":0.0006327529,"teacher_disagreement_score":0.00063048827,"about_ca_system_score_codex":0.00030036597,"about_ca_system_score_gemma":0.000131325,"threshold_uncertainty_score":0.002179265},"labels":[],"label_agreement":null},{"id":"W2941016857","doi":"10.1080/07357907.2019.1601209","title":"Antitumor and Antiangiogenic Activities of Lenvatinib in Mouse Xenograft Models of Vascular Endothelial Growth Factor-Induced Hypervascular Human Hepatocellular Carcinoma","year":2019,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; Eisai","keywords":"Lenvatinib; Cancer research; Vascular endothelial growth factor; Hepatocellular carcinoma; Medicine; Angiogenesis; Umbilical vein; Receptor tyrosine kinase; Kinase insert domain receptor; Vascular endothelial growth factor A; Internal medicine; Sorafenib; VEGF receptors; Receptor; Biology; In vitro","score_opus":0.03175972106769036,"score_gpt":0.24783670264573465,"score_spread":0.21607698157804428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941016857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436754,0.0018243061,0.0016199785,0.000095621355,0.000040136627,0.000052916526,0.00039780914,0.00009467386,0.0015070167],"genre_scores_gemma":[0.99488395,0.0011658733,0.0014982716,0.00004034872,0.000012747658,0.00006592042,0.00052438595,0.000015915894,0.0017924746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998229,0.00005242507,0.000014947715,0.000020735535,0.000040400806,0.000048670154],"domain_scores_gemma":[0.99991846,0.000011429878,0.00001635084,0.000010833229,0.000010170599,0.000032854838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025129697,0.00048460235,0.00042538697,0.00044079867,0.000145476,0.00022627252,0.000167105,0.00025404495,0.0009780583],"category_scores_gemma":[0.00007282537,0.00017176519,0.00023557407,0.00027961237,0.00017449641,0.0002555338,0.00009724328,0.0008730378,0.00016940237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006670148,0.00043054455,0.00024684865,0.000046277088,0.000016323771,0.00004577883,0.000014255142,0.0002705784,0.99549556,0.00011701523,0.00008050649,0.0025691467],"study_design_scores_gemma":[0.00009020676,0.002617889,0.0028721082,0.000004553306,0.000030664247,0.00018445138,0.0000181025,0.0020887263,0.9909271,0.000039941875,0.0011207073,0.000005490031],"about_ca_topic_score_codex":0.000884944,"about_ca_topic_score_gemma":0.001218408,"teacher_disagreement_score":0.0009780583,"about_ca_system_score_codex":0.00034302226,"about_ca_system_score_gemma":0.0003173799,"threshold_uncertainty_score":0.0032719374},"labels":[],"label_agreement":null},{"id":"W3002686079","doi":"10.1080/07357907.2020.1720223","title":"Amplification of Chromosome 17 Centromere (CEP17) in Breast Cancer Patients with a Result of HER2 2± by Immunohistochemistry","year":2020,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Essar Steel Algoma (Canada); Sault Area Hospital; NOSM University","funders":"","keywords":"Chromosome 17 (human); Breast cancer; Internal medicine; Biology; Immunohistochemistry; Chromosome; Medicine; Fluorescence in situ hybridization; Cancer; Pathology; Genetics; Gene","score_opus":0.026211123835748643,"score_gpt":0.3091500376235991,"score_spread":0.28293891378785047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002686079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99922395,0.0004184075,0.00009893169,0.000010162885,0.0000029049284,0.0000070781716,0.000043717093,0.0000014399336,0.00019342049],"genre_scores_gemma":[0.9996681,0.0001465705,0.00007393928,0.000007029528,0.000005123283,0.0000047183757,0.00005861531,7.652427e-7,0.000035167293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994779,0.00011011191,0.00007337651,0.000103167964,0.00014894079,0.000086531494],"domain_scores_gemma":[0.99823296,0.0005710388,0.0008350022,0.00006367327,0.00016743371,0.0001298858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000716557,0.0001820695,0.0002819905,0.0011683818,0.00023133788,0.00034325564,0.00023215188,0.00024511485,0.0015647471],"category_scores_gemma":[0.00227731,0.00020143317,0.00017710464,0.0007949489,0.00031147996,0.00030679334,0.00031919233,0.00018554374,0.0002470406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015723199,0.00000869362,0.99636227,0.000013937483,0.000013141115,0.0010773685,0.00004388747,0.000010782508,0.0008678006,0.0000064929773,0.000029864448,0.0014085739],"study_design_scores_gemma":[0.000010087634,0.00021953182,0.9864624,0.000015088553,0.000060576625,0.011864784,0.00023360373,0.00013152396,0.0006013787,0.000022434888,0.00037459595,0.000003923814],"about_ca_topic_score_codex":0.0005223908,"about_ca_topic_score_gemma":0.0005592422,"teacher_disagreement_score":0.0015647471,"about_ca_system_score_codex":0.00015854443,"about_ca_system_score_gemma":0.00017239181,"threshold_uncertainty_score":0.005234599},"labels":[],"label_agreement":null},{"id":"W4286221730","doi":"10.1080/07357907.2022.2104305","title":"Suspension of Oncology Randomized Clinical Trials during the COVID-19 Pandemic: A Cross-Sectional Evaluation of COVID-Related Suspensions","year":2022,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Medicine; Odds ratio; Clinical trial; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Randomized controlled trial; Cross-sectional study; Pandemic; Internal medicine; Odds; Cross over; Virology; Logistic regression; Pathology; Medical physics; Disease; Outbreak","score_opus":0.573353065216519,"score_gpt":0.5992513498065951,"score_spread":0.025898284590076148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286221730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.787902,0.073217064,0.037639473,0.006464894,0.0012868058,0.023564026,0.060541946,0.00083559554,0.008548215],"genre_scores_gemma":[0.94559866,0.00300238,0.018034909,0.0027361016,0.0004134764,0.017539984,0.011687769,0.0002295637,0.00075720594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.5745794,0.3030038,0.07234826,0.024726896,0.021303823,0.0040378384],"domain_scores_gemma":[0.26572245,0.5116643,0.16693434,0.03670185,0.014994052,0.003983046],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.30142015,0.0014671393,0.0037145885,0.0039775125,0.0014420582,0.004695648,0.002147268,0.0021675467,0.008251419],"category_scores_gemma":[0.5134708,0.001989171,0.0095773395,0.00750766,0.0023344727,0.0057299584,0.0043786997,0.0039321766,0.0011353672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067601465,0.0014807574,0.6868667,0.021958094,0.14409886,0.00042916,0.0018181539,0.00460743,0.0009478862,0.0041696196,0.014588821,0.051433112],"study_design_scores_gemma":[0.030906208,0.029717857,0.74476296,0.010679229,0.096420325,0.0025709749,0.0020043491,0.015361218,0.0032366714,0.008990784,0.054779503,0.000569903],"about_ca_topic_score_codex":0.0013240107,"about_ca_topic_score_gemma":0.0023365826,"teacher_disagreement_score":0.69857985,"about_ca_system_score_codex":0.002508788,"about_ca_system_score_gemma":0.0049442733,"threshold_uncertainty_score":0.8614733},"labels":[],"label_agreement":null},{"id":"W4297785721","doi":"10.1080/07357907.2022.2122488","title":"Routine Skin Cancer Screening: Balance between Overdiagnosis and Prevention","year":2022,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Overdiagnosis; Declaration; Medicine; Balance (ability); Cancer; Dermatology; Internal medicine; Computer science; Physical therapy","score_opus":0.04334994949258634,"score_gpt":0.3067660097177656,"score_spread":0.2634160602251792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297785721","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2992755,0.14626227,0.015098462,0.40657705,0.0040480252,0.00047071214,0.0005715605,0.00080924254,0.12688725],"genre_scores_gemma":[0.8826448,0.04369332,0.011888268,0.04693124,0.0057200934,0.0001933876,0.00024790972,0.00019888843,0.008482173],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99653435,0.0013428857,0.00023241862,0.00032374717,0.0012004344,0.0003662073],"domain_scores_gemma":[0.98898333,0.0060455934,0.0012969668,0.00038402484,0.0014314165,0.0018587265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052518914,0.00039295646,0.0009484609,0.0014802276,0.00078528305,0.0025648314,0.00066559133,0.0016631996,0.01162754],"category_scores_gemma":[0.019677324,0.00025994368,0.00046246953,0.00067319983,0.0006245557,0.0018770939,0.0015029144,0.0017943359,0.0018783102],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011778016,0.0009114265,0.082952835,0.001751875,0.0003158281,0.00020141942,0.0003861533,0.0004203263,0.0023593635,0.004441138,0.04308443,0.8619974],"study_design_scores_gemma":[0.0007243968,0.0041779806,0.7532899,0.012476989,0.0012732118,0.005093981,0.0043027718,0.0048516337,0.0032287794,0.027542949,0.18282834,0.00020901917],"about_ca_topic_score_codex":0.0024967445,"about_ca_topic_score_gemma":0.0062279734,"teacher_disagreement_score":0.01162754,"about_ca_system_score_codex":0.0012619783,"about_ca_system_score_gemma":0.001915074,"threshold_uncertainty_score":0.03889793},"labels":[],"label_agreement":null},{"id":"W4399765412","doi":"10.1080/07357907.2024.2363879","title":"Prognostic Effects of Sarcopenia on Patients with Bladder Cancer: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcopenia; Medicine; Meta-analysis; Internal medicine; Bladder cancer; Cochrane Library; Subgroup analysis; Cancer; Oncology; Overall survival","score_opus":0.11492701280648701,"score_gpt":0.40934432836194756,"score_spread":0.2944173155554606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399765412","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051386696,0.9935638,0.00030234503,0.00014936237,0.00009688434,0.00018019306,0.0003905623,0.000016060585,0.00016219565],"genre_scores_gemma":[0.1492566,0.84607565,0.0016058962,0.0007437839,0.00024745494,0.00089575024,0.00086398347,0.00002367808,0.00028730524],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99436307,0.0024415387,0.001770377,0.0005800579,0.00061619136,0.00022885694],"domain_scores_gemma":[0.98953897,0.0075977664,0.0015501564,0.00032732307,0.0008146869,0.00017109881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008664285,0.0024368716,0.015258069,0.00654493,0.0007574535,0.0027740796,0.0017078146,0.0021112263,0.002918033],"category_scores_gemma":[0.020111147,0.00145727,0.03939323,0.006921623,0.00052869075,0.0015422447,0.0015116113,0.0018298938,0.00023944041],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018516692,0.00004045501,0.006391592,0.37076992,0.60555863,0.00015429832,0.000099954515,0.000537535,0.0002201023,0.00010672868,0.00059072516,0.0136783905],"study_design_scores_gemma":[0.00034176474,0.00014190559,0.0042445622,0.0211065,0.9724768,0.00008500822,0.000037708825,0.0001783048,0.00007298518,0.00011522032,0.0011780722,0.000021137934],"about_ca_topic_score_codex":0.007242906,"about_ca_topic_score_gemma":0.018724535,"teacher_disagreement_score":0.015258069,"about_ca_system_score_codex":0.0019324806,"about_ca_system_score_gemma":0.0034931607,"threshold_uncertainty_score":0.045821667},"labels":[],"label_agreement":null},{"id":"W4401425810","doi":"10.1080/07357907.2024.2388107","title":"The Landscape and Prognosis of Microsatellite Stable (MSS) Esophageal, Gastro-Esophageal Junction and Gastric Adenocarcinomas with High Tumor Mutation Burden (TMB)","year":2024,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Essar Steel Algoma (Canada); Sault Area Hospital","funders":"","keywords":"Mutation; Esophageal adenocarcinoma; Medicine; Esophagogastric junction; Microsatellite; Internal medicine; Microsatellite instability; Cancer research; Esophageal cancer; Gastroenterology; Adenocarcinoma; Cancer; Oncology; Biology; Gene; Genetics; Allele","score_opus":0.013157268460202601,"score_gpt":0.23988201665073752,"score_spread":0.22672474819053492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401425810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994742,0.00012996583,0.000024704601,0.000017822878,7.857525e-7,8.34131e-7,0.00023315163,0.0000023387895,0.00011619826],"genre_scores_gemma":[0.9995215,0.000041362822,0.000027638927,0.000006212952,0.000002713958,9.1407475e-7,0.00035345298,9.119728e-7,0.000045252098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998702,0.000024777517,0.000015985916,0.00003715494,0.000022532793,0.00002939831],"domain_scores_gemma":[0.9994497,0.00007544614,0.00029013318,0.00003472335,0.000039966864,0.00011012518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016908138,0.000120262324,0.00017122997,0.00076899026,0.00019142327,0.00040277766,0.00012704813,0.00021983428,0.0014789912],"category_scores_gemma":[0.00092092634,0.00010678528,0.00012806227,0.0006669416,0.00020593592,0.00024634087,0.00035755086,0.00014536036,0.0001965127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013602909,0.000007494411,0.9969078,0.0000064514493,0.000025825,0.00014642681,0.000025999787,0.000028222204,0.0014179803,0.000015914617,0.00005493782,0.0012269713],"study_design_scores_gemma":[0.000001700182,0.000035395035,0.9987797,0.0000017259189,0.000013110022,0.000776732,0.00006936287,0.0000827981,0.00012597733,0.000026354983,0.000085910375,0.0000011470408],"about_ca_topic_score_codex":0.0012061691,"about_ca_topic_score_gemma":0.0018673483,"teacher_disagreement_score":0.0014789912,"about_ca_system_score_codex":0.00014074131,"about_ca_system_score_gemma":0.00011260018,"threshold_uncertainty_score":0.004947722},"labels":[],"label_agreement":null},{"id":"W4415356814","doi":"10.1080/07357907.2025.2570382","title":"Examining the Direct and Indirect Effects of Socioeconomic Status on Colorectal Cancer Using Structural Equation Modeling","year":2025,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research; National Natural Science Foundation of China","keywords":"Socioeconomic status; Structural equation modeling; Colorectal cancer; Family history; Generalized estimating equation; Cancer","score_opus":0.0607860370334072,"score_gpt":0.3164312972078801,"score_spread":0.2556452601744729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415356814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99006796,0.00048919383,0.007867926,0.0005172581,0.000024731755,0.00010504157,0.0004464601,0.000026443295,0.00045498967],"genre_scores_gemma":[0.9934278,0.00026438577,0.0054445704,0.00004883579,0.000013517115,0.00013153261,0.0004392117,0.000004905277,0.00022528098],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.989553,0.008798466,0.00028399317,0.00050516473,0.0005447458,0.00031467213],"domain_scores_gemma":[0.9831976,0.014395394,0.0011262984,0.0006173066,0.00044092815,0.00022240105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012952956,0.0010273067,0.0009758515,0.0016377713,0.00046846314,0.000915339,0.00089286483,0.0006609185,0.0014741115],"category_scores_gemma":[0.026280925,0.0006226324,0.003092929,0.0020799213,0.0006922286,0.0006870253,0.0011945468,0.0011339606,0.000111400404],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042167623,0.00023212959,0.9787709,0.0000898024,0.0037662315,0.0001459079,0.0005262889,0.0064392453,0.00022500982,0.0012356117,0.0001997694,0.007947419],"study_design_scores_gemma":[0.00032553822,0.0016795405,0.80167913,0.00017836627,0.004821415,0.00038439658,0.0008188429,0.18178545,0.0006779709,0.0064553553,0.0011347472,0.000059221795],"about_ca_topic_score_codex":0.026786761,"about_ca_topic_score_gemma":0.030751076,"teacher_disagreement_score":0.026786761,"about_ca_system_score_codex":0.00096567493,"about_ca_system_score_gemma":0.002180188,"threshold_uncertainty_score":0.068502605},"labels":[],"label_agreement":null},{"id":"W4416983134","doi":"10.1080/07357907.2025.2596854","title":"Breast Cancer Susceptibility: Meta-Analysis of Cytochrome P450 2C19 ( <i>CYP2C19</i> ) and Estrogen Receptor-1 ( <i>ESR1</i> ) Genetic Variants","year":2025,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genetic variants; Breast cancer; Estrogen; Cytochrome P450; CYP2C19; Estrogen receptor; Genetic variation","score_opus":0.01827648228667883,"score_gpt":0.2783405185910849,"score_spread":0.26006403630440605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416983134","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05920741,0.92509675,0.008086712,0.0015475205,0.0006459998,0.00023309993,0.003651715,0.00025162756,0.0012791395],"genre_scores_gemma":[0.8497205,0.1384216,0.0064158766,0.0010798816,0.0004329527,0.0004789444,0.0024153623,0.00014543635,0.00088948035],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98906904,0.006769703,0.0014523036,0.0016393975,0.0006969778,0.00037265106],"domain_scores_gemma":[0.9801988,0.0158379,0.0014750527,0.0014463722,0.0007853762,0.0002564377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01468153,0.0023545062,0.008176537,0.0037429854,0.0006843008,0.002758265,0.001791193,0.0015085227,0.0043269475],"category_scores_gemma":[0.028397826,0.001005379,0.036072616,0.005639007,0.00054613204,0.0010514646,0.0012744397,0.001657388,0.00036168902],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002785593,0.000020177817,0.029478911,0.02621928,0.92908126,0.0001875516,0.000046913126,0.0018387071,0.0006299945,0.000217957,0.0011708234,0.008322822],"study_design_scores_gemma":[0.00046033564,0.00019117513,0.015448576,0.0020689024,0.97785944,0.00014546151,0.00003230504,0.0008926644,0.00028987136,0.0005165082,0.0020767797,0.0000179847],"about_ca_topic_score_codex":0.008715672,"about_ca_topic_score_gemma":0.011354164,"teacher_disagreement_score":0.01468153,"about_ca_system_score_codex":0.0012403174,"about_ca_system_score_gemma":0.001924232,"threshold_uncertainty_score":0.07764429},"labels":[],"label_agreement":null},{"id":"W7117321436","doi":"10.1080/07357907.2025.2599381","title":"Diagnostic Costs of Metastatic and Unknown Primary Cancers in Alberta, Canada, 2017–2021","year":2025,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health; Alberta Health Services","funders":"","keywords":"Stage (stratigraphy); Cancer; Diagnostic test; Cost analysis; Disease; Cost driver; Health care; Baseline (sea); Total cost","score_opus":0.015751605423678344,"score_gpt":0.2763654839179671,"score_spread":0.26061387849428874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117321436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9613327,0.007086701,0.0002767237,0.0030857383,0.00009789664,0.00010505972,0.01871171,0.000045964778,0.009257547],"genre_scores_gemma":[0.98617077,0.0028987485,0.0003597742,0.0002954642,0.000044698616,0.000021411335,0.0070635653,0.000008436576,0.0031371042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895775,0.000098183766,0.00005317702,0.00007161294,0.00046120945,0.00035793462],"domain_scores_gemma":[0.9980914,0.00018131414,0.0003882481,0.00002891301,0.00073505024,0.00057505624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005838995,0.00034807908,0.0003394105,0.0015653758,0.0013179472,0.0015419032,0.0010528098,0.00033903905,0.0021146566],"category_scores_gemma":[0.0030431487,0.00029054563,0.00067688036,0.0035559747,0.00047206876,0.0002987102,0.0007523707,0.00093148154,0.00014925902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005090627,0.00010725607,0.9421198,0.00026286577,0.00025051486,0.0008035863,0.00047373812,0.003675802,0.00028184548,0.0012352251,0.014027378,0.03625303],"study_design_scores_gemma":[0.000049497543,0.00006350115,0.98837143,0.00014618733,0.00011688307,0.0005152207,0.0016076398,0.003136526,0.00012875801,0.00016338451,0.0056757554,0.000025106223],"about_ca_topic_score_codex":0.99328655,"about_ca_topic_score_gemma":0.9962453,"teacher_disagreement_score":0.07145075,"about_ca_system_score_codex":0.07145075,"about_ca_system_score_gemma":0.046777893,"threshold_uncertainty_score":0.5184139},"labels":[],"label_agreement":null}]}